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Abstract 
 
The past four decades have witnessed tremendous strides in the evolution of 
endovascular devices and techniques. Catheter-based intervention has revolutionized 
the management of arterial disease allowing treatment of aortic and peripheral 
pathologies via a minimally invasive approach. Despite the exponential advances in 
endovascular equipment, devices and techniques, catheter-based endovascular 
intervention has certain morphological and technological constraints. Complex patient 
anatomy, technological impediments and suboptimal fluoroscopic imaging, can make 
endovascular intervention challenging using traditional endovascular means. 
Conventional endovascular catheters lack active manoeuvrability of the tip. Manual 
control can hinder overall stability and control at key target areas, leading to 
significantly prolonged overall procedure and fluoroscopic times. Repeated 
instrumentation increases the risk of vessel trauma and distal embolization. More 
importantly, guidewire-catheter skills are not necessarily intuitive but must be 
developed and are highly dependent on operator skill with long training pathways as a 
result. 
 
Recognizing the pressing need to address some of the limitations of standard catheter 
technology this thesis aims to evaluate the role of advanced robotic endovascular 
catheters in the aortic arch and the visceral segment. Clinical use of this technology is 
currently limited to transvenous cardiac mapping and ablation procedures. A 
comprehensive pre-clinical comparison and analysis of robotic versus manual catheter 
techniques is presented to reveal both their advantages and limitations, with particular 
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emphasis on the potential of robotic catheter technology to reduce the manual skill 
required for complex tasks, improve stability at key target areas, reduce the risk of 
vessel trauma, embolization and radiation exposure, whilst improving overall operator 
performance. The worlds first clinical report of robot-assisted aortic aneurysm repair, 
a “proof - of - concept” resulting from this research, is also presented, and the 
potential for future advanced applications in order to increase the applicability of 
endovascular therapy to a larger cohort of patients discussed. 
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Chapter 1. 
Endovascular Intervention 
 
1.1?The evolution of Endovascular Therapy 
 
Vascular Surgery is a rapidly evolving speciality driven largely by new advances in 
technology and a desire to perform less invasive procedures for patients that have 
significant co-morbidities. The advent of endovascular therapy has revolutionized the 
management of arterial disease allowing treatment of aortic and peripheral 
pathologies via a minimally invasive approach. It has also allowed treatment of 
patients whose respiratory and cardiovascular co-morbidities would have rendered 
them unsuitable and high risk for surgery. In a population with atherosclerosis, the 
number of minimally invasive catheter-based endovascular procedures has steadily 
risen as a result of increased operator experience, the availability of more 
sophisticated and versatile endovascular tools, and advances in imaging modalities 
[EVEM data, 2010]. 
 
The past four decades have witnessed tremendous strides in the evolution of 
endovascular devices and techniques. Early pioneering efforts provide a valuable 
insight into the technical complexities vascular specialists face in their pursuit of 
minimally invasive therapies for the aorta and its branches. In 1953, Ivan Seldinger 
made the first step from diagnostic to therapeutic angiography by describing the use 
of a guidewire technique to establish arterial access [Edholm P et al, 1956]. A decade 
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later, Thomas Fogarty developed the first balloon-tip catheter for peripheral arterial 
embolectomy [Fogarty TJ et al, 1965], and on the same principle, Charles Dotter first 
described the use of endovascular dilating catheters to treat an atherosclerotic stenosis 
[Dotter CT et al, 1964]. The concept of catheter-based intervention adopted by 
Greenfield et al led to the development of vena cava filters that have revolutionized 
the treatment of pulmonary thromboembolism [Greenfield LJ et al, 1973]. Further 
advances in catheter technology and manufacture provided Andreas Gruentzig with 
low-profile co-axial balloon systems; in 1974 he performed the first coronary artery 
balloon angioplasty, the most commonly performed endovascular intervention to date 
[Grüntzig A, 1979]. The adoption of balloon angioplasty catheters subsequently led to 
the introduction of the first intravascular balloon-expandable stent by Palmaz et al in 
1985 [Palmaz JC et al, 1985]. Endovascular therapy has been described as a form of 
disruptive technology: “a new technology that displaces the standard old method for 
performing certain functions because the new method is so clearly better than the 
old” - Frank Veith [Veith FJ, 2008]. The use of endovascular technology to treat 
aneurysmal and occlusive arterial disease has produced results comparable if not 
improved, to those that can be achieved with conventional open surgical approaches 
in certain vascular beds. This has led to an overall increase in the vascular practice 
volume due to the broader applicability of these minimally invasive techniques to a 
larger patient population that would otherwise be deemed unsuitable for surgery. This 
thesis will investigate the potential role of endovascular robotic technology in 
complex vascular intervention focusing on two of the most challenging and disruptive 
applications of endovascular therapy: aneurysmal disease of the aorta and carotid 
artery disease.  
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1.1.1. Aneurysmal disease of the aorta 
 
Aneurysmal disease of the aorta continues to be a major cause of death worldwide 
and the incidence increases with age, with 85% of all cases occurring in patients aged 
65 and above [National Center for Health Statistics, 2007]. Aneurysm size, growth 
rate and smoking appear to be the most significant predictors of aneurysm rupture. 
Eighty percent of all aneurysms are thought to be degenerative and atherosclerotic in 
nature, with a further 15% due to dissection and the remainder secondary to 
connective tissue disorders, arteritis and trauma [Griepp RB et al, 1999].  
 
Since the first reported case by Dubost et al in 1952 [Dubost C et al, 1952] and 
subsequent modifications to the original technique, conventional open aneurysm 
repair became the mainstay of treatment for the next 30 years. Open infra-renal aortic 
aneurysm (IRAAA) repair requires general anaesthesia, a large abdominal incision, 
and cross clamping of the aorta in order to sew in a new prosthetic graft to replace the 
diseased segment. For thoraco-abdominal aortic aneurysms (TAAAs), defined by the 
involvement of the coeliac, superior mesenteric, renal and arch vessel origins, open 
repair represents an even more formidable task.  Access to the aorta is gained through 
a thoraco-abdominal incision dictated by TAAA extent proximally, and division of 
the diaphragm. The clamp and sew technique with revascularization of major aortic 
branches, often requiring cardiopulmonary bypass with hypothermic circulatory 
arrest, single-lung ventilation, and cerebrospinal fluid (CSF) drainage/ epidural 
cooling, resulting in long operative times, significant blood loss, volume shifts, and 
prolonged recovery times. Despite significant advances in surgical technique and peri-
operative critical care the traditional open repair, even in the most experienced 
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centres, is still associated with high morbidity and mortality rates: 1.4–6.5% for non-
ruptured and 23–69% mortality for ruptured IRAAAs [Ernst CB, 1993; McPhee J et 
al, 2009], and 8 - 30% for non-ruptured and 50 – 80% for ruptured, more extensive 
TAAAs, with a paraplegia incidence of up to 16% [Svensson LG et al, 1993; Safi HJ 
et al, 1998; Rigberg DA et al, 2006; Coselli JS et al, 2007; Schepens MA et al, 2007]. 
 
In 1991, Parodi et al combined both Dacron graft and balloon-expandable stent 
technology to create the first endovascular stent-graft for an infra-renal abdominal 
aortic aneurysm and introduced the concept of endovascular aneurysm exclusion 
[Parodi JC et al, 1991]. By 1994, Dake et al had published the first series of 
successful endovascular stent-grafting for isolated descending thoracic aortic 
aneurysms with no reported paraplegia [Dake MD et al, 1994]. Rapid advances in 
stent-graft technology and availability of improved devices have revolutionized the 
treatment of aneurysmal disease of the abdominal and thoracic aorta via a minimally 
invasive approach. In contrast to the traditional open repair, endovascular stent-
grafting utilizes small groin incisions or a percutaneous approach for femoral artery 
access. It can be performed using regional or even local anaesthesia. The device is 
introduced through the femoral arteries and deployed under fluoroscopic guidance. 
The diseased aortic segment is relined, rather than replaced, with the endovascular 
stentgraft. This technique obviates the need for a large abdominal incision and aortic 
cross- clamping and hence minimizes blood loss and the physiological insult to the 
patient.  
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Infra-renal aortic segment - EVAR: 
 
Several retrospective reviews, registries and prospective clinical trials have compared 
outcomes of endovascular aortic aneurysm repair (EVAR) for IRAAAs with those of 
conventional open repair [Zarins CK et al, 1999; Harris PL et al, 2000; Lee WA et al, 
2001; Matsumura JS et al, 2003; Moore WS et al, 2003; Bush RL et al, 2006] and 
demonstrated reduced morbidity rates, reduced blood loss, shortened hospital stay, 
faster recovery times and encouraging short-term outcomes. The two large 
randomized controlled trials (RCTs) that followed, the Dutch Randomised 
Endovascular Aneurysm Management trial (DREAM) and EVAR-1 trials, confirmed 
the benefits of the less-invasive nature of endovascular repair and concluded that peri-
operative mortality is lower following endovascular repair than with open repair 
(1.2% versus 4.6% in DREAM and 1.7% versus 4.7% in EVAR-1) [Prinssen M et al, 
DREAM 2004; Greenhalgh RM et al, EVAR-1 2004, Greenhalgh RM et al, 2010]. 
Data from both trials showed that all-cause mortality was similar in the endovascular 
repair and open repair groups (at approximately 11%-DREAM and 28%-EVAR-1), 
although there were persistently fewer aneurysm-related deaths in the endovascular 
group than in the open repair group (5.7% versus 2.1%-DREAM and 4% versus 7%-
EVAR-1); the 3% operative mortality benefit from EVAR in terms of AAA-related 
deaths, was maintained at four years [Blankensteijn JD et al, 2005; De Bruin JL et al, 
2010, Greenhalgh RM et al, 2010]. Both the EVAR and DREAM trials reported a 
higher rate of re-intervention over time following endovascular repair than open 
repair (20% versus 6% in the EVAR-1 trial). In the EVAR-1 trial, which enrolled 
patients between 1999 and 2004 from 37 hospitals in the United Kingdom, all-cause 
mortality curves in the two groups converged at two years and aneurysm-related 
 20 
mortality curves converged at six years. However, between 30 days and 4 years after 
aneurysm repair, the majority of deaths in each group were due to either cancer or 
ischemic heart disease, and the all-cause and aneurysm-related mortality curves 
remained equivalent out to 8 years. The EVAR-2 trial which compared stenting to no 
intervention in those unfit for open aneurysm repair, showed that EVAR had a 
considerable 30-day operative mortality in patients already unfit for open repair, 
however it was associated with a significantly lower rate of aneurysm-related 
mortality than no repair [Greenhalgh RM et al, 2010, Brown LC et al, 2010]. The US-
led Open Versus Endovascular Repair (OVER) RCT that compared post-operative 
outcomes up to 2 years after endovascular versus open elective AAA repair showed 
that peri-operative mortality was low for both approaches but lower for endovascular 
than open repair; the early advantage of endovascular repair was not offset by 
increased morbidity or mortality in the first 2 years on follow-up [Lederle FA et al, 
2009]. 
 
These RCT trials have fuelled considerable debate among the vascular community. 
Both the EVAR-1 and EVAR-2 trials were limited by long delays between 
randomization and treatment, with 14 patients dying while awaiting EVAR. 
Moreover, 27% of patients in EVAR-2 crossed over from non-operative to 
endovascular repair, and these patients had a lower procedure mortality from EVAR 
than those originally assigned to it (2% v 9%). The results from these RCTs are also 
inherently linked to early devices and imaging technology, limited experience and 
outdated secondary treatment. The EVAR-1 trial was designed before the 2002 
Society for Vascular Surgery reporting standards on EVAR were published [Chaikof 
EL et al, 2002]. Complications therefore reported in EVAR-1, especially with regards 
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to endoleaks and subsequent interventions are not applicable to current practice. 
Endoleaks, defined as persistent blood flow outside the lumen of an stent-graft but 
within an aneurysm sac or adjacent vascular segment, result from incomplete sealing 
or exclusion of the aneurysm sac, and thus cause reflux of blood flow and continued 
pressurization into the sac, leaving the patient at risk of aneurysm rupture [Cao P et al, 
2010]. There are three main endoleak types: type I is a proximal (Type Ia) or distal 
Type (Ib) leak at the endograft ends resulting from inadequate seal at the 
corresponding landing zones, Type II endoleaks result from sac filling via collateral 
branch vessels (e.g. lumbars or the inferior mesenteric artery), and Type III endoleaks 
results from a leak through a defect in the graft fabric or ineffective sealing of 
overlapping graft joints. The EVAR Investigators defined all endoleaks as 
complications; there were a total of 288 patients with complications in the EVAR 
group versus 72 patients in the open group. Among all patients with complications, 
156 were type II endoleaks (in 108 EVAR patients and and 3 open repair patients). 
Current practice in accordance with the Society for Vascular Surgery reporting 
standards, states that Type II endoleaks are often benign and may result in 
spontaneous resolution. The majority require observation, with intervention being 
reserved for patients with persistent endoleaks and aneurysm sac expansion. In terms 
of other complications and re-interventions, earlier stentgraft devices, which had an 
increased incidence of migration and late failure, are now rarely used. The concept of 
“freedom from re-intervention” after open repair is now also challenged: recent 
population-based studies show that patients undergoing open aneurysm repair are 12 
times as likely to undergo laparotomy and adhesiolysis for small bowel obstruction in 
the future and that re-admission for non-operative management of bowel obstruction 
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that occurs more frequently after open repair is associated with a 30-day mortality of 
10.9%. [Schermerhorn ML et al, 2010].   
 
In recent years, with advances in device technology and increasing operator 
experience, criteria for treatment as well as for re-interventions are now better 
understood. Considerable emphasis is shifted towards improving patient fitness prior 
to treatment, particularly in terms of cardiac, respiratory and renal co-morbidities, and 
EVAR has become a durable and reliable option for those that are anatomically 
suitable. In addition to elective repair, after the initial report of successful 
endovascular repair of a ruptured abdominal aortic aneurysm (AAA) in 1994 [Yusuf 
SW et al, 1994], the use of endovascular stent-grafts for ruptured AAAs has been 
increasing, and several prospective trials and retrospective case series have shown 
reduced peri-operative morbidity and mortality rates as well as length of hospital stay 
especially in the high-risk group of patients [Ohki T et al, 1999; Hinchliffe RJ et al, 
2001; Lee WA et al, 2004; Alsac JM et al, 2005; Dillavou ED et al, 2006; Dillon M et 
al, 2007]. A randomized controlled trial is currently underway [Powell JT et al, 2009]. 
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Thoracic aortic segment-TEVAR: 
 
It is in the thoracic aorta that endovascular stent grafting is having its greatest impact 
in terms of its perceived advantage, where it has rapidly become the first line therapy 
for much thoracic aortic pathology with defined indications for therapeutic 
intervention. Comparison of endovascular and conventional surgical techniques has 
shown a clear mortality advantage to the endovascular option (25% versus 5–10%) 
and a reduction in the incidence of paraplegia of less than 5%, not only for thoracic 
aneurysms but also for other aortic pathologies such as transections, acute aortic 
syndromes, complicated type-B aortic dissections, fistulae and other thoracic 
catastrophes [Leurs LJ et al, 2004; Makaroun MS et al, 2005; Cambria RP et al, 2009; 
Chiesa R et al, 2010; Ullery BW et al, 2011; Jonker FH et al, 2011, Patel HJ et al, 
2011]. Endovascular reconstruction of the true lumen for acute complicated type-B 
dissections in particular, is becoming increasingly popular. Cumulative extraction of 
currently available outcomes data and meta-analytic interpretation of the available 
observational evidence suggest that endovascular stent grafts provide improved 
survival compared with the open surgical approach in these complicated type-B 
dissection cases presenting with organ malperfusion, impending rupture, ongoing 
pain, and resistant hypertension [Nienaber CA et al, 2011; White RA et al, 2011; 
Steuer J et al, 2011]. The absolute benefit of thoracic endovascular aneurysm repair 
(TEVAR) over alternative treatments for chronic uncomplicated Type-B dissections, 
however, remains uncertain. A single RCT, the INSTEAD (Investigation of 
Stentgrafts in Aortic Dissection) trial, demonstrated that in the setting of 
uncomplicated type-B aortic dissections, elective stentgraft placement in conjunction 
with optimized medical management fails to improve survival and adverse events 
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within an observation period of 2 years, despite favorable aortic remodelling 
[Nienaber CA et al, 2009]. The lack of natural history data and the significant 
heterogeneity in case selection in published reports, constitute significant obstructions 
to interpreting mid-term results for these cases [Thrumurthy SG et al, 2011]. The less 
invasive nature of endovascular stent grafting in the thoracic aorta, however, and the 
encouraging outcomes for specific pathologies have led many investigators to 
speculate that the technique may expand the applicability of endovascular 
intervention. High-quality data from registries such as the International Registry of 
Acute Aortic Dissection [Trimarchi S et al, 2011] and randomized control trials are 
required to define consensus; the ADSORB (Acute Uncomplicated Aortic Dissection 
Type B: Evaluating Stent-Graft Placement or Best Medical Treatment Alone) trial, a 
randomized controlled trial investigating the role of TEVAR in acute dissections, is 
currently underway [Tang DG et al, 2009, Brunkwall JS, 2011].  
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Thoraco-abdominal aortic segment: 
 
The Hybrid approach 
 
Although the use of endovascular stent grafts for isolated infra-renal or thoracic aortic 
aneurysms has shown significant promise, their use for extensive TAAAs is limited 
by the presence of the aortic arch vessels proximally and the visceral and renal vessels 
distally. In 1999, Quinones-Baldrich et al were the first to report a combined 
endovascular and open surgical approach for a type-IV TAAA, involving retrograde 
visceral bypass revascularization followed by successful completion endo-grafting 
and TAAA exclusion [Quinones-Baldrich WJ et al, 1999]. In 2003, the St Mary’s 
Vascular Unit at Imperial College independently developed a retrograde extra-
anatomical visceral/renal debranching technique with completion endo-grafting for 
extensive TAAAs [Rimmer J et al, 2003]. Extra-anatomical bypass grafts from the 
aorta or iliac artery - depending on the distal extent of the TAAA - provide retrograde 
flow into each visceral and renal vessel allowing end-organ perfusion; the proximal 
artery is ligated to eliminate the risk of back bleeding into the aneurysmal sac. This 
approach limits the physiological derangements associated with proximal aortic cross-
clamping, thoracotomy and single-lung ventilation in the traditional open repair. Our 
unit has reported the largest published series of these repairs for high-risk patients, 
with a 30-day mortality rate of 14.95% and a paraplegia rate of 8.4% [Black SA et al, 
2006; Drinkwater SL et al, 2009], and the technique has now been adopted by various 
centres worldwide [Resch TA et al, 2006; Zhou W et al, 2006; Chiesa R et al, 2007]. 
Aneurysms that involve the more proximal descending thoracic aorta or the aortic 
arch may also require extra-anatomic bypasses of the subclavian, brachiocephalic and 
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carotid arteries with subsequent stenting of the distal thoracic segment or surgical 
replacement of the arch utilizing elephant trunk techniques to allow stent placement 
[Greenberg RK et al, 2005; Holt PJ et al, 2010; Antoniou GA et al, 2010; Chiesa R et 
al, 2010; Xydas S et al, 2010; Younes HK et al, 2010]. 
 
The wholly endovascular approach: 
fenestrated and branch stent-graft technology 
 
Further advances in stent-graft technology in recent years, have allowed the treatment 
of more extensive aneurysm pathology, via an even less invasive, wholly 
endovascular approach, avoiding extensive aortic exposure whilst maintaining 
visceral branch perfusion, especially in patients unable to withstand the traditional 
surgical approach due to significant co-morbidities. New-generation custom-made 
fenestrated and branched devices were designed to extend the proximal sealing zone 
from the infra-renal segment to the supra-renal and thoraco-abdominal aorta by 
incorporating the visceral and supra-aortic branches. These sophisticated devices 
require fenestrations (windows) or formal directional branches to be made into the 
grafts according to individual patient anatomy, to maintain vital aortic branch 
perfusion.  
 
Having gained access through the groin or via an iliac conduit, the fenestrated device 
is placed at the level of the target vessels under fluoroscopic imaging aligning the 
fenestrations with the target vessel ostia to allow cannulation, subsequent side-branch 
stenting and overall exclusion of the aneurysm.  With branched devices, the aortic 
main body is deployed well above the target vessel, the branches are cannulated from 
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a brachial approach, and self-expanding stentgrafts are deployed to join the branch 
vessels with the main aortic body endograft. 
 
In 1999 Browne et al first reported the use of a custom-made device in canine models 
[Browne TF et al, 1999]. Initial clinical experiences with these devices in a combined 
series of 16 patients with short-necked infra-renal aneurysms and no incidence of 
acute vessel loss or death were later described [Anderson JL et al, 2001; Stanley BM 
et al, 2001]. Several clinical reports have followed early experiences [Greenberg RK 
et al, 2004; Verhoeven EL et al, 2004] and recent reviews on fenestrated endografting 
for the juxta-renal segment demonstrated a peri-operative mortality of 1.1%, with 
97% of the target vessels patency [Sun Z et al, 2006; O’Neill S et al, 2006]. 
Extrapolating fenestrated technology above the infra-renal segment to treat aneurysms 
involving the visceral arteries, was initially described by Anderson et al in 2005 
[Anderson JL et al, 2005]. The first reported case of TAAA repair involved a 
homemade device with longitudinally oriented branches [Chuter TA et al, 2001]. 
Subsequently, a number of series have been published describing the results of 
endovascular repair of complex aneurysms with technical success range ranging from 
90-98%, with 5-9% mortality, a paraplegia rate of 3% and significantly reduced 
length of hospital stay tom a median of 9 days [Greenberg RK et al, 2006; Muhs BE 
et al, 2006; Roselli EE et al, 2007; Bicknell et al, 2009; Haulon S et al, 2010].  
 
In selected patients, fenestrated and branched stent-grafting appears to be a safe and 
effective alternative to open and hybrid surgery for juxtarenal and thoracoabdominal 
aneurysms, with encouraging short and intermediate-term results [Greenberg RK et 
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al, 2008]. The procedure is currently developing and gaining acceptance; its long-term 
durability, however, is yet to be proven. 
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1.1.2 Carotid artery disease 
 
Carotid artery stenosis, almost invariably atherosclerotic, is a frequent clinical 
problem. It can be asymptomatic or symptomatic presenting as one or more transient 
ischemic attacks relating to embolization of thrombus from stenotic lesions, 
hypoperfusion, or less commonly, as an ischemic stroke. Stroke is the third leading 
cause of death and the leading cause of serious, long-term disability. Approximately 
15 million people suffer a stroke worldwide each year [Lloyd-Jones D et al, 2010]. 
Carotid endarterectomy (CEA) is currently the gold standard of treatment for the 
management of carotid artery disease for the prevention of stroke. Felix Eastcott is 
credited with the first carotid revascularisation in a symptomatic patient, performed in 
1954 at St Mary’s Hospital [Eastcott HHG et al, 1954], whereas Michael De-Bakey, 
at the Methodist Hospital in Houston, developed and established the technique 
worldwide [DeBakey ME et al, 1975]. Six decades on, the management of carotid 
artery disease has been the subject of much controversy with regards to indication for 
treatment, diagnostic modalities, patient selection, treatment options, technical skill 
and operator experience. 
 
There is strong evidence from high-quality prospective RCTs that surgical 
intervention is beneficial for carotid artery disease in symptomatic patients with an 
internal carotid artery stenosis of greater than 70%; the risk of stroke in such high-
grade cases when treated with medical therapy alone, can be as high as 26% 
[Mayberg MR et al, 1991; ECST Collaborators 1991; NASCET Collaborators 1991; 
Rothwell PM et al, 2003]. The North American Symptomatic Carotid Endarterectomy 
Trial (NASCET) demonstrated a 17% reduction in absolute stroke risk by two years 
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after CEA i.e. for every six patients treated, one major stroke can be prevented 
(number needed to treat (NNT)=6). Symptomatic patients with moderate stenoses (50 
– 69%) have a smaller benefit, with a NNT of 22 at five years. In symptomatic 
patients with less than 50% stenosis, medical therapy is superior to surgical treatment.  
 
The role of surgery for asymptomatic stenosis remains controversial. Another two 
high-quality trials estimated the average annual risk of stroke to be approximately 2% 
in asymptomatic patients with 60–99% stenosis treated with best medical therapy, 
versus 1% with surgical intervention [ACAS Committee, 1995; ACST Collaborators, 
2004]. However, a recent systematic review and a number of natural history studies 
argue that with improvements in medical therapy in recent years, the average annual 
rate of ipsilateral stroke with best medical therapy alone can be as low as 0.34% 
[Abbott AL, 2009; Marquardt L et al, 2010]. Although the indications for surgical 
treatment of asymptomatic carotid disease are not clearly defined, identification of 
patients at risk of suffering a stroke is crucial so that interventions can be targeted and 
tailored to individual patient characteristics. It is important, therefore, to emphasize at 
this point, that risk stratification should not merely reflect stenosis severity and the 
presence or absence of symptoms. More sophisticated parameters such as plaque 
morphology, plasma biomarkers, stenosis progression, embolisation on transcranial 
Doppler and infarction on CT/MRI imaging should also be taken into account [Bladin 
C et al, 2010, Naylor AR 2011]. 
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Carotid Artery Stenting 
 
Over the past decade, carotid artery stenting (CAS) has emerged as a less invasive 
alternative to CEA. It is assumed that, by stent implantation, carotid plaque 
composition is modified such that the lesion becomes less vulnerable to rupture and 
embolisation. Given the widespread adoption and success of endovascular therapy in 
other vascular beds, there are several potential advantages of minimally invasive 
intervention especially in patients with cardiac co-morbidities, those with high-grade 
re-stenosis, hostile necks following radiation or radical neck surgery, or patients with 
inaccessible high cervical lesions.  Overall, a minimally invasive endoluminal 
procedure is less dependent on patient co-morbidities and eliminates the risk of 
cranial nerve injury and may reduce hospital stay. Carotid balloon angioplasty was 
first performed in 1980 [Mathias K, 1981; Bockenheimer SA et al, 1983], and an 
endovascular stent was first used in 1989 to treat an intimal flap lesion following 
angioplasty [Théron J, 1992]. Since then, there has been a series of non-randomised 
and randomised trials as well as registries to assess the safety and efficacy of 
percutaneous carotid intervention.  
 
Although there are substantial variations in procedural protocol and technique 
amongst endovascular specialists, the standard technique for CAS is described below. 
The procedure is performed in the angiography suite under fluoroscopic guidance. 
Under local anaesthesia, access is obtained via the femoral artery or in some cases via 
the brachial approach. The target carotid artery is cannulated using a 5F catheter in 
combination with a 0.035 inch guide wire. Standard angiographic projections to 
demonstrate the carotid bifurcation are obtained, along with intracranial views to 
assess the collateral circulation for any evidence of intracranial stenotic lesions. With 
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the catheter positioned in the common carotid artery (CCA), an exchange-length 
0.035 inch wire is advanced into the external carotid artery (ECA). The catheter is 
exchanged over the wire for a guiding catheter or a long sheath that is then advanced 
into the CCA below the carotid bifurcation. Depending on the severity of the stenosis, 
the lesion in the internal carotid artery (ICA) is firstly crossed by an embolic 
protection device (EPD) – a specifically designed umbrella-shaped device that is used 
to capture debris and emboli. Balloon predilation may also be necessary if the stenosis 
is very severe. Once the lesion in crossed, a sheath-covered self-expanding stent is 
introduced and positioned in the stenotic portion of the ICA artery. Following stent 
deployment, an angiogram is obtained to confirm the increase in diameter of the 
artery. In severe cases of stenosis, the stent itself may only reduce the occlusion 
mildly. To overcome any residual stenosis, a balloon catheter may be placed within 
the stent and expanded to allow for greater augmentation of the vessel diameter, and 
after successful postdilation the EPD is removed, using a retrieval catheter. The 
technique has evolved with great contributions from industry providing lower profile 
systems, improved stents, and a variety of EPDs.  
 
Data from isolated experienced centres, registries and one RCT indicate that CAS can 
be as effective as CEA in the prevention of ipsilateral stroke [Wholey MH et al, 2003; 
Yadav JS et al, 2004; Theiss W et al, 2008; Zahn R et al, 2008; SAPPHIRE 
Investigators, 2008; Gray WA et al, 2009]. All other RCTs, however, including the 
recent CREST trial – the largest RCT to date – have demonstrated increased rates of 
cerebral embolization for CAS in comparison to CEA for symptomatic disease 
[Eckstein HH et al, 2008; Mas JL et al, 2008; CAVATAS Investigators, 2009; Ederle 
J et al, 2009; International Carotid Stenting Study Investigators, 2010; Mantese VA et 
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al CREST Investigators, 2010]. Compared with the surgical approach, the 
endovascular procedure is associated with a significant cerebral embolic burden 
[Bonati LH et al, 2010]. The excess risk of peri-procedural neurological 
complications observed in CAS seems to be multifactorial: poor patient selection, 
plaque morphology, tortuosity, angulation and complex aortic arch anatomy (bovine 
or Type III arch variants), device technology and operator experience, all play an 
important role. The low adverse event rates observed when CAS was performed 
extensively in registries in the early part of the century, led some CAS enthusiasts to 
believe that carotid surgery was to become obsolete and that CAS would replace the 
old gold standard, CEA. Since the appearance of the unacceptably high stroke rates 
reported in some RCTs and the controversy that followed, many of the original CAS 
enthusiasts went on to express a note of caution and the need for improved 
technology, experienced CAS operators and careful patient selection, avoiding those 
with complex anatomy or high- grade calcified lesions (Macdonald S et al, 2009; 
Naylor AR 2011).  
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1.2?Current Endovascular Tools 
 
Stent-graft technology, from the early infra-renal devices to the more sophisticated 
fenestrated and branched endografts as illustrated above, is rapidly evolving, allowing 
more complex aortic pathology to be treated via the minimally invasive route.  
Endovascular guidewires, catheters and sheaths comprise the foundation of 
endovascular therapy both technically and conceptually and are essential for safe 
stentgraft deployment.  
 
 
Guidewires 
 
Whether diagnostic or interventional, current endovascular devices are rarely 
sufficiently manoeuvrable without the use of a guidewire. Guidewires are used to 
introduce, position and exchange catheters and other endovascular tools (Fig 1.2.1). 
They serve the purpose of creating a pathway through the vascular system, whilst 
achieving and maintaining critical access across target areas.  
 
All guidewires are composed of a stiff inner core and an outer tightly coiled spring, 
which allows a catheter to track over the guidwire. The guidewire tip may be pre-
formed into a straight, angled or J-curved tip, and “floppy” to minimize vessel wall 
trauma. Most commonly used wires are coated with a hydrophilic polymer similar to 
silicone, which facilitates passage through vessels and catheter exchanges. External 
torque devices can be employed to increase control of these wires (rotational 
movement of the ex vivo portion results in rotation of the in vivo portion). For access 
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to a specific target within a vessel, branch cannulation, or lesion crossing, a standard 
guidewire length of 145 to 180 cm is usually adequate. Exchange-length guidewires 
function to provide support and trackability to various catheters introduced over them. 
To facilitate exchange of catheters while maintaining a lesion crossing therefore, 
stiffer and longer (260–300 cm) exchange-length guidewires are used to minimize 
kinking. The standard guidewire diameter for peripheral interventions is 0.035 inch, 
and more recently due to improved guidewire construction, an increasing number of 
endoluminal procedures can be performed using 0.014 or 0.018 inch wires, to 
minimize vessel wall trauma. 
 
 
Fig 1.2.1 A range of endovascular guidewires 
 
 
A range of commonly used endovascular guidewires, essential for the introduction, positioning and exchange of 
catheters and other endovascular tools. 
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Conventional Catheters 
 
A broad range of endovascular catheters is currently available, that vary in their pre-
formed distal ends, hydrophilic nature, torquability, pushability, and flexibility. The 
majority of catheters manufactured today are composites, with a stiffer material for 
the main catheter body and a more flexible material for the soft tip. They have a 
diameter of 4 to 6F -with 5F catheters being by far the most common- and lengths 
ranging from 65 cm to 150 cm. Most catheters are advanced over a wire to minimize 
intimal injury, and can be non-selective or selective. Non-selective catheters are 
designed to rapidly infuse large volumes of contrast agent without causing injury to 
the vessel. Their distal portion contains multiple side-holes in addition to the standard 
end-hole and is preformed into a shape (usually a ‘pigtail’) that assists in the 
dispersion of contrast. These catheters have a high tensile strength - yet a low 
coefficient of friction, to be able to resist high burst pressures associated with high 
injection rates, and still maintain their predetermined shape in order to advance 
through tortuous vessels. They must also have low thrombogenicity. 
 
Selective catheters with a single end-hole are designed for cannulation of branch 
vessels. A wide range of preformed distal ends is available to assist in selective 
cannulation of various anatomical targets (Fig 1.2.2). Catheters with curved distal 
ends are usually introduced over a guidewire with a floppy tip, so that they may 
assume their preformed shape when the guidewire is withdrawn with its distal tip 
within the catheter lumen. In catheterization of branch vessels with an acute 
angulation from the direction of approach such as a left subclavian or left carotid 
artery, reverse curve catheters or catheters with a secondary curve are designed for 
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engaging the vessel lumen. These double-curved catheters are first advanced past the 
target branch vessel and require manual re-shaping involving interaction with the 
vessel wall in the aorta proximal to the area of interest before the catheter is 
withdrawn back with the catheter tip directed toward the access site. To reshape, the 
catheter is advanced until the tip and primary curve are no longer supported by the 
guidewire. Then with the tip engaged in a side branch, the main body of the catheter 
is either advanced or rotated, reforming the catheter into its native shape. 
Alternatively, a catheter may be reformed by reflection off the aortic valve when 
cannulating branches in the aortic arch such as the carotid arteries.   
 
Fig 1.2.2 A range of conventional selective catheters 
 
 
 
 
 
 
 
 
 
 
 
A range of conventional, selective endovascular catheters with preformed distal ends to assist in selective 
cannulation of various anatomical targets. 
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Sheaths 
 
Introducer sheaths are essential for carheter/guidewire exchanges and the introduction 
of endografts and other endovascular tools; they are designed to minimize vessel 
trauma and extravasation of blood while maintaining vascular access. Sheaths are 
inserted over a primary access guidewire after cannulation of the access vessel 
(usually the common femoral artery) using the Seldinger technique (Fig 1.2.3). 
Appropriately sized dilators aid the insertion of the larger sheath into the small 
puncture made by the puncture needle. Subsequent to insertion, all exchanges or 
introduction of guidewires, catheters, and devices takes place through the sheath 
lumen. Sheaths and dilators are usually constructed of Teflon (tetrafluoroethylene), a 
material of low coefficient of friction that is very torquable. Nearly all sheaths feature 
a haemostatic valve and a side infusion port. 
 
Large-diameter sheaths (20–24 F) are available for deployment of aortic endografts 
and often these sheaths are included into the endograft delivery system. Sheath 
lengths range from 10 cm to 65 cm. The 10 to 15cm length is standard for most 
peripheral vascular interventions. Longer length sheaths are usually only needed for 
endograft placement or access to the contralateral side of the main aortic body. When 
the common femoral artery is either undersized or too diseased to facilitate access, 
creation of an iliac conduit using a 10mm Dacron graft is indicated to allow the 
introduction of necessary sheaths. Brachial or radial access may also be required in 
some procedures; these sites will usually accommodate insertion of a 4F sheath.  
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Fig 1.2.3 An endovascular sheath 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sheaths are designed to minimize vessel trauma and extravasation of blood while maintaining vascular access. 
They are inserted over a primary access guidewire using the Seldinger technique. 
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1.3?Limitations in endovascular intervention  
 
Motivation and proposal 
 
Despite the exponential advances in endovascular equipment, devices and techniques, 
endovascular intervention has certain morphological and technological constraints. 
Anatomical unsuitability due to complex patient anatomy, technological impediments 
as well as poor visualization of key regions of the arterial tree, can make endovascular 
intervention challenging using traditional endovascular means. 
  
Radiation exposure and nephrotoxicity are other important factors that should be 
considered. All endovascular procedures are currently performed under fluoroscopic 
guidance. Technically complex cases inevitably take longer to perform and this 
increases both radiation exposure and contrast load. Recommendations to minimize 
radiation exposure for both of the patient and the operator include keeping 
fluoroscopic time to a minimum and maximizing working distance from the radiation 
source. Operators working 80cm from the radiation source receive 25% of the scatter 
dose received by those 40 cm from the source [Ho P et al, 2007]. Iodinated contrast 
agents are required to demonstrate the intravascular anatomy during these procedures, 
and they are nephrotoxic as they exacerbate the physiological hypoxia in the outer 
renal medulla leading to oxidative stress [Walsh SR et al, 2008]. Peri-operative renal 
failure is a key determinant of outcome for AAA repair, with significantly increased 
mortality rates in patients requiring renal replacement therapy [Wong GT et al, 2007]; 
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measures therefore should be taken to limit the use of contrast load during 
endovascular repair.  
 
Complications specific to endovascular intervention should also be taken into 
account. Both the EVAR and DREAM trials demonstrated a higher rate of re-
interventions over time following endovascular repair than open repair (20% versus 
6% in the EVAR-1 trial) [Greenhalgh RM et al, 2010]. Endograft migration with 
earlier devices, kinking and disruption of modular endograft components, and 
endoleak formation are all potential complications and therefore lifetime surveillance 
must be maintained [Chuter TA, 2009; Resch T et al, 2010]. Critics of endovascular 
technology often highlight its increasing costs.  The EVAR-2 trial which compared 
stenting to no intervention in those unfit for open aneurysm repair, showed that the 
mean hospital cost per patient in the intervention group over four years was £13,632 
(approx. $24,720 USD) compared with £4,983 (approx. $9,219 USD) in the non-
intervention group [Greenhalgh RM et al, 2010]. The inherent cost for the custom-
made branched and fenestrated devices in particular, also mandates careful 
consideration. 
 
Current catheter technology has its own limitations. Conventional endovascular 
catheters have a limited repertoire of shapes and sizes, they are difficult to steer and 
lack active manoeuvrability at the tip. The delivery of torque at the distal end is also 
impeded by the unanticipated contact friction between the catheter and the access 
vessel at the proximal end. This manual control can hinder overall stability and 
control at key target areas. This necessitates frequent catheter changes, which can 
threaten the stable positioning of guidewires and result in loss of vessel access and 
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significantly prolonged overall procedure and fluoroscopic times. Access vessels can 
be tortuous and angulated; non-compliant rigid vessels increase the risks of iatrogenic 
vessel damage while making catheter control more challenging. Repeated 
instrumentation especially in the presence of vessel thrombus or calcification 
increases the risk vessel dissection, perforation and distal embolization.  The latter is 
particularly pertinent in instrumentation within the aortic arch, where cerebral 
embolization may occur, resulting in stroke [Bonati LH et al, 2010]. 
Microembolisation of vessel plaques has been identified as a causative factor for 
spinal cord ischaemia [Berg P et al, 2001], renal impairment [Boules TN et al, 2007], 
and peripheral arterial ischaemia [Maldonado TS et al, 2004]. Iliac tortuosity can 
cause further problems with catheter control and manipulation. Graft rotation and 
misalignment of fenestrations/branches with the vessel ostia, due to angulation of the 
more proximal aortic segment in fenestrated and branched stent-grafting procedures, 
may further prevent easy and safe target vessel cannulation. More importantly, 
guidewire-catheter skills are not necessarily intuitive but must be developed; 
conventional catheter manipulation requires a high degree of technical performance, 
operator skill and long training pathways as a result [Neequaye SK et al, 2007].  
Limitations specific to complex aneurysm repair and arch vessel intervention will be 
discussed in detail in later chapters.  
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Research Aims 
 
Recognizing the pressing need to address some of the limitations of standard catheter 
technology this research aims to evaluate the role of advanced robotic endovascular 
catheters for complex arterial intervention in the aortic arch and the visceral segment. 
Clinical use of this technology is currently limited to transvenous cardiac mapping 
and ablation procedures. A comprehensive pre-clinical comparison and analysis of 
robotic versus manual catheter techniques is presented to reveal both their advantages 
and limitations, with particular emphasis on the potential of robotic catheter 
technology to reduce the manual skill required for complex tasks, improve stability at 
key target areas, reduce the risk of vessel trauma, embolization and radiation 
exposure, whilst improving overall operator performance. The worlds first clinical 
report of robot-assisted aortic aneurysm repair, a “proof - of - concept” resulting from 
this research, is also presented and the potential for future advanced applications in 
order to increase the applicability of endovascular therapy to a larger cohort of 
patients discussed. 
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Chapter 2. 
Robotic Technology 
 
Robot-assisted surgery, surgical telemanipulation or computer-assisted surgery, are 
being developed to overcome human limitations and eliminate impediments 
associated with conventional surgical and interventional tools. Robotic technologies 
are increasingly being used by surgical disciplines to facilitate and improve 
performance of minimally invasive surgery and have been shown in many fields to 
significantly improve outcomes [Howe RD et al, 1999; Lanfranco AR et al, 2004]. 
Laparoscopic and endovascular techniques have both been introduced into the field of 
vascular surgery with specific advantages to patient outcomes [Ludemann R et al, 
1999; Rouers A et al, 2005; Nio D et al, 2007; Lovegrove RE et al, 2008]. There has 
been an increasing interest in the application of robotic technology to enhance 
minimally invasive laparoscopic capabilities in the vascular tree.  
 
In this chapter, a review of the current status of clinical applications and supporting 
evidence of robotics in vascular surgery is undertaken, followed by a description of 
the Hansen Sensei endovascular robotic system used in this research work. 
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2.1. Robotics in vascular surgery 
 
Currently available laparoscopic robotic systems 
 
Two advanced surgical robotic systems have been used in laparoscopic vascular 
surgery:  the da Vinci (Intuitive Surgical Inc., Mountain View, CA) and Zeus 
(Computer Motion Inc., Santa Barbara, CA) systems [Martinez BD et al, 2004]. Of 
these, only the da Vinci system remains in current use for laparoscopic surgery, since 
the acquisition of Computer Motion by Intuitive Surgical and the corporate decision 
to stop production of the Zeus robot [Hanly EJ et al, 2004]. Both systems are 
comprehensive master-slave surgical robots with similar capabilities [Kim HL et al, 
2004]. The da Vinci system consists of three components: the vision cart, the master 
surgeon console and the robotic platform. The vision system has a dual light source 
and cameras, which generate a stereoscopic image. The surgeon operates from a 
console, which is located away from the patient. The surgeon console contains an 
image-processing computer, which provides a 3-dimensional view of the operative 
field with adjustable magnification, a view port, instrument and camera arm clutches, 
and foot pedals for electrocautery. In addition, there is motion scaling, tremor 
elimination and an ergonomic working position for the surgeon. Using manipulators, 
the surgeon’s hand movements are digitally registered through sensors, and then 
transferred to the robotic instrument cart. Two or three robotic instrument arms and a 
camera arm are mounted on this mobile cart. The articulating laparoscopic 
instruments provide 7 degrees of freedom. The Zeus robotic system consisted of a 
surgeon control console and three separate robotic arms attached to the sidebars of the 
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operating table; two arms held surgical instruments and the third arm was a voice-
integrated control endoscope for visualization.     
 
 
Clinical applications in laparoscopic vascular procedures 
 
The first report on robot-assisted laparoscopic aortic surgery was published in 2002; 
Wisselink et al used the Zeus robotic system to construct the proximal aortic 
anastomosis of an aorto-bifemoral bypass from a console remote from the operating 
table in two patients with aorto-iliac occlusive disease [Wisselink W et al, 2002]. A 
systematic literature search identified nine studies reporting on robot-assisted 
laparoscopic surgery for infra-renal aortic pathologies [Wisselink W et al, 2002; 
Desgranges P et al, 2004; Killewich LA et al, 2004; Kolvenbach R et al, 2004; Nio D 
et al, 2005; Stádler P et al, 2006; Diks J et al, 2007; Stádler P et al, 2008; Stádler P, 
2009]. These are either case reports or case series, and after excluding publications 
with duplicate cases, four papers reporting on a total of 162 patients were analyzed 
(Table 2.1.1).  
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Table 2.1.1 Case series of robotically assisted laparoscopic vascular procedures 
 
 
 
Author   Kolvenbach et al   Desgranges et al   Diks et al   Stádler et al 
 
 
Year   2003    2004    2007   2009 
Number of patients  10    5    17   130 
Robot   Zeus    Da Vinci    Zeus 5, Da Vinci 12  Da Vinci 
Operation   10 AAA    5 AOD    17 AOD   115 AOD,  
11 AAA,  
2 CIAA, 2 other 
 
Conversion (n)  2 (hand-assisted)   1 (open)    3 (open)   3 (mini or full  
laparotomy) 
 
Reason   NR    external conflicts  1 technical (robot)  1 difficulty  
for conversion    between robotic arms  1 bleeding lumbars  excluding CIAA 
1 difficult dissection 2 bleeding 
(lumbars, 
anastomosis)  
 
Operative time 
(min)  242 (mean)   188 (mean)   365 (median)  215 (median) 
Clamping time  
(min)  96 (mean)    75 (mean)    86 (median)  43 (median) 
 
Blood loss (ml)  NR    540 (mean)   1000 (median)  380 (median) 
Morbidity  1 [ARF]    1[ischaemic colitis]   1 [bleeding  3 [MRSA  
(number[cause])        from prosthesis]  1 incisional  
hernia,1 graft 
occlusion] 
Mortality  
(number[cause]) None    None    1 [MI]   None 
 
Hospital stay (days)  7 (mean)    8 (mean)    4 (median)  5 (median) 
Follow up (months)  NR    8 (mean)    18 (median)  NR 
 
 
 
AOD, aorto-iliac occlusive disease; AAA, abdominal aortic aneurysm; CIAA, common iliac artery aneurysm; ARF, acute 
renal failure; MI, myocardial infarction; NR, not reported 
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The Zeus and da Vinci system were used to perform the aortic anastomosis in 15 and 
147 cases respectively. Of the 162 procedures, 137 were performed for aorto-iliac 
occlusive disease, 21 for abdominal aortic aneurysms and 2 for common iliac artery 
aneurysm repair; the type of operation was not clarified in two cases. The conversion 
rate ranged from 3% to 20%, with technical problems related to the robotic system 
and bleeding from the lumbar arteries being the most common reasons for conversion. 
Morbidity rates ranged from 3% to 20%. One peri-operative death from myocardial 
infarction was described, resulting in an overall mortality rate of 0.6%. Only one 
comparative study of conventional laparoscopic and robot-assisted aortic surgery was 
identified, which demonstrated shorter anastomosis time in the robotic group, even 
though the total operating time was longer due to the technical complexity of the 
robotic device [Kolvenbach R et al, 2004]. 
 
Recent reports have extended the application of robotic technology beyond the 
construction of the aortic anastomosis. A technique of using robotic surgery as a sole 
modality for repair of an abdominal aortic aneurysm with sac exclusion and 
obliteration has been described [Wu T et al, 2009]. Furthermore, robotic devices have 
been used in other complex reconstructive arterial procedures such as renal and 
splenic artery aneurysm reconstructions [Luke P et al, 2006; Pietrabissa A et al, 
2010]. A further step in the applicability of robotic surgery was undertaken to 
complement and enhance endovascular procedures. Robotic ligation of an inferior 
mesenteric artery for the treatment of a persistent type II endoleak after endovascular 
aneurysm repair has been reported [Lin JC et al, 2009]. Computer-assisted robotic 
technology has also been used as an adjunct to hybrid surgical debranching and 
endovascular repair of a TAAA aneurysm [Wahlgren CM et al, 2008].    
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Supporting evidence for the use of robotic systems in laparoscopic vascular surgery 
 
Robotic instrumentation was initially evaluated in animal models with the 
implantation of infrarenal aortic grafts [Martinez BD et al, 2004]. The results obtained 
from this study showed that both da Vinci and Zeus robotic systems were effective in 
performing aortic anastomoses with the surgeon operating from a console away from 
the operating table. Another animal study investigated the hypothesis that robotic 
systems, with improved imaging and surgeon dexterity, might facilitate aortic 
laparoscopic procedures [Ruurda JP et al, 2004]. Comparison of the performance of 
robot-assisted and standard laparoscopic surgery revealed the superiority of the 
former, as evidenced by shorter procedure, suturing and clamping times, and less 
blood loss. The feasibility of robotic-assisted aortic anastomosis has also been tested 
in the thoracic aorta of animal models using the closed-chest technique [Tozzi P et al, 
2003; Smith JM et al, 2005]. Of interest, the anastomosis time and haemostasis were 
found to be comparable between running suture techniques using the da Vinci system 
and interrupted nitinol clips. 
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2.2. Endovascular Robotics  
 
Currently available endovascular robotic systems 
 
Two main types of endovascular robotic systems have been developed, with different 
mechanisms of action: magnetically controlled systems such as the Niobe magnetic 
navigation system (Stereotaxis, USA) and electromechanical-based systems such as 
the Hansen Sensei robotic navigation system (Hansen Medical, USA).  
 
Magnetically controlled Systems 
 
The function of the Niobe remote-controlled magnetic navigation system is based on 
a magnetic field created by two computer-controlled 0.08T permanent magnets. 
Adjustment of the orientation and intensity of these magnets and subsequently the 
magnetic field, results in deflection of the catheter, which is equipped with magnetic 
implants in its tip. A computer-controlled catheter advancing system allows the 
operation to be remotely performed. This system can be used with 7-8 F diagnostic 
and ablation catheters with up to 120 degree bend radius. Use of the system also 
requires a dedicated 0.014 inch coronary guidewire (Stereotaxis). The wire contains a 
magnet embedded in its tip that allows the tip to be deflected by the surrounding 
magnetic field, and is advanced manually. It is not hydrophilic and does not have 
"memory." The stiffness of the wire is less than most commonly used guidewires. The 
Niobe system also requires refurbishment of the interventional laboratory to 
accommodate for the applied magnetic field. 
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A more recent robotic system to be developed using the same magnetic principal is 
the Maxwell Catheter Guidance, Control and Imaging system (Engineered Magnetics, 
Inc., California, USA), which uses eight electromagnets to guide a magnetically 
tipped catheter. These are fixed magnets that can vary the direction of the magnetic 
field. This system is not hindered by the lag time associated with rotation of the 
magnet and has a focused magnetic field. 
 
 
 
 
 52 
Electromechanically controlled Systems – The Hansen Sensei 
 
The Hansen Sensei System controls a guide catheter via a “master-slave” 
electromechanical mechanism by digitally translating the hand motion of the operator. 
It allows visualization and positioning of the catheter tip at a desired point, while 
enabling the operator to remain seated at a remote workstation. This steerable catheter 
control system consists of three main components. 
 
The workstation  
 
The workstation is located remotely and away from the radiation source. It consists of 
the central computerized “master” input device, an Instinctive Motion Controller 
(IMC), a 3D hand-operated joystick, and screens that display imaging and force 
sensing data (Fig 2.2.1). This allows for the guide catheter to replicate the hand 
movement of the operator via the IMC joystick, delivering control in three 
dimensions, with seven degrees of freedom and visual force-sensing quantification as 
well as haptic feedback. The main fluoroscopic control view also displays a 
superimposed icon of the guide catheter with vectors for planar orientation and 
navigation. 
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Fig 2.2.1 The remote robotic workstation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The workstation is located remotely and away from the radiation source. It consists of the central computerized 
“master” input device, an Instinctive Motion Controller (IMC), a 3D hand-operated joystick, and screens that 
display imaging and force sensing data. 
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The remote catheter manipulator (RCM) 
 
The RCM is located at the patients’ bedside and delivers the robotically steerable 
guide catheter (Artisan™, Hansen Medical). It receives catheter position commands 
from the “master” input device at the workstation, as issued by the IMC. The RCM is 
controlled via motors and tension wires that ultimately determine the position of the 
catheter tip. The RCM also has the ability to insert the entire Artisan forward and 
rotate it with a 270-degree bend radius (Fig 2.2.2). 
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Fig 2.2.2 The remote catheter manipulator 
 
 
  
 
 
 
The RCM is located at the patients’ bedside and delivers the robotically steerable guide catheter. It receives 
catheter position commands from the “master” input device at the workstation, as issued by the IMC. 
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The robotic catheter   
 
The Artisan robotic catheter consists of a flexible, multidirectional inner guide (11 F 
outer diameter, 8.5 F inner diameter) within a unidirectional outer guide sheath (14 F 
outer diameter, 11F inner diameter) (Fig 2.2.3). The inner guide has four embedded 
pull wires that deflect the catheter via internal sensors in a multidirectional fashion 
through tension controlled by the main console. The outer guide sheath provides 
stability and allows the entire system to rotate. This catheter system creates a 
workspace defined by a bend of up to 270 degrees with 10 cm extension of the inner 
guide. The steerable catheter in the current Hansen Sensei system may be directed 
over an independent wire, but does not depend on that wire to manoeuvre within the 
vasculature. A force quantification system (IntellisenseTM Technology, Hansen 
Medical) has also been developed, and involves the introduction of an impedance 
force sensor through the Artisan catheter that allows constant measurements of 
catheter-tissue contact. 
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Fig 2.2.3 The robotic catheter (Artisan™, Hansen Medical) 
 
 
 
 
 
 
The Artisan robotic catheter consists of a flexible, multidirectional inner guide (11 F outer diameter, 8.5 F inner 
diameter) within a unidirectional outer guide sheath (14 F outer diameter, 11F inner diameter). This creates a 
workspace defined by a bend of up to 270 degrees with 10 cm extension of the inner guide. 
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Clinical applications in endovascular therapy 
 
Remotely controlled steerable catheter navigation and vessel cannulation in the 
arterial tree is a novel approach in the field of endovascular arterial intervention.  
 
Supporting evidence for the use of robotic endovascular catheters in the arterial tree 
 
Experience with computerized robotically controlled catheter systems was initially 
obtained in transvenous cardiac mapping and ablation procedures for the treatment of 
cardiac arrhythmias. Early investigations in animal models demonstrated the 
feasibility and safety of navigation within cardiac chambers and facilitation of 
transseptal puncture; no intracardiac damage associated with catheter manipulation 
occurred [Saliba W et al, 2006]. In another animal study, an electromechanical robotic 
catheter system was evaluated for its ability to navigate within the heart and precision 
in ablation as compared with conventional ablation catheters [Al-Ahmad A et al, 
2005]. Τhis study demonstrated reduced navigation time and precision targeting 
associated with the use of the robotically controlled system. The transition from pre-
clinical to clinical application of the Hansen Sensei robotic catheter system was 
associated with promising results. Preliminary experience of remote navigation for 
catheter ablation for the treatment of a variety of cardiac arrhythmias demonstrated its 
safety and clinical efficacy, as well as reduction in radiation exposure; the results 
were similar to conventional approaches for cardiac ablation [Kanagaratnam P et al, 
2008; Saliba W et al, 2008, Di Biase L et al, 2009]. 
 
 
 59 
2.3. Conclusions 
 
Robotic technology has the potential to enhance surgical intervention by extending 
human capabilities. Robotic systems can manipulate tools more accurately and 
steadily, by incorporating hardware and software filters, which eliminate 
physiological tremor. With remote manipulation, the comfort and ergonomics of the 
operator is significantly increased, with reduced fluoroscopic exposure for the 
operator in cases of x-ray guided interventions. These systems can also be integrated 
with more advanced 3-D imaging modalities with depth perception and adjustable 
magnification. The enhancement of laparoscopic vascular surgery with robotic 
systems has not been widely adopted by vascular communities and its role is not fully 
established. Experience is restricted to a few centres worldwide, which have 
demonstrated technical feasibility with satisfactory results. Comparative trials will be 
required to assess the true value of robotic laparoscopic surgery compared with 
conventional laparoscopic and open aortic surgery to be able to quantify the 
advantage of robotic technology and aid in justifying its cost.  
 
Endovascular robotic technology in the arterial tree currently represents a virgin field 
of study. Some of the key advantages of laparoscopic robotic technology and its 
applications in vascular surgery may apply to complex endovascular intervention. The 
adoption of this advanced telemanipulation systems may enhance precision and 
dexterity in performing complex endovascular tasks and may be of value in 
overcoming the long learning curves associated with minimally invasive intervention.  
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Chapter 3. 
 
Endovascular robotics for fenestrated 
stent grafting 
 
3.1?Background 
Advances in stent-graft technology have allowed the treatment of complex TAAA 
disease via a less invasive, totally endovascular approach. Fenestrated and branched 
stent grafting of aneurysmal juxta-renal and TAAA aortic segments and aneurysms 
that involve the supra-aortic vessels using custom-made stent grafts is an appealing 
concept, given the high morbidity associated with this condition and especially in 
patients unable to withstand the traditional surgical approach due to significant co-
morbidities. The procedure is currently developing and gaining acceptance with 
encouraging short and intermediate-term results [Chuter TA et al, 2001; Verhoeven 
EL et al, 2004; Anderson JL et al, 2005; Sun Z et al, 2006; O’Neill S et al, 2006; 
Greenberg RK et al, 2006; Muhs BE et al, 2006; Roselli EE et al, 2007; Bicknell CD 
et al, 2009]. 
 
Despite an accurate custom-made device design, however, target vessel cannulation 
can be technically challenging and time consuming, especially in the presence 
complex anatomy including tortuous iliac arteries and an angulated visceral aortic 
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segment, with long fluoroscopic exposure times as a result. Conventional pre-shaped 
selective catheters have limited maneuverability, and require a high degree of finesse 
by the operator in order to safely position the catheter tip at the vessel ostia and 
maintain stability at target sites during passage of stiff wires and endovascular tools 
[Moore R et al, 2007; Bicknell et al, 2008] (Fig 3.1.1). 
 
The purpose of this study was to investigate whether this complex endovascular 
procedure can be enhanced by a remotely steerable robotic endovascular catheter 
system, which may overcome some of the difficulties described above. The study 
compares robotic and conventional endovascular catheter techniques with respect to 
time, accuracy, and overall performance scores for target vessel cannulation within a 
pulsatile silicone phantom model. 
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Fig 3.1.1 Difficulties with conventional catheter manipulation 
 
 
 
Bridging the gap between the fenestration/target vessel ostium interface with conventional endovascular catheters 
can be challenging. Often, the catheter passes through the fenestration, however, due to limited manoeuvrability 
and torquability it fails to engage the target vessel ostium from the aneurysm sac, with repeated cannulation 
attempts and long fluoroscopic times as a result. An intra-aortic molding balloon can be used to prevent upward 
angulation and subsequent displacement of the wire from the target vessel when a less flexible catheter is passed, 
and facilitate therefore introduction of guiding catheters in fenestrated stent-graft procedures. This technique 
however, can be utilized when the fenestration is remote from the top cap of the main aortic body device. 
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3.2?Methodology 
 
Aortic model 
 
A silicone-based, transparent, computed tomography (CT)-reconstructed 
anthropomorphic phantom representing a TAAA aneurysm was used (Elastrat Sàrl, 
Geneva, Switzerland). The aorta was dilated throughout its length (5.2 cm visceral 
segment diameter) with marked aneurysmal dilatation of the infra-renal segment (8.1 
cm maximum diameter). This model was chosen as infra-renal fixation would not be 
achievable due to lack of landing zone proximally, necessitating repair with 
fenestrated stent grafting of the visceral and supra-renal segment. The phantom was 
filled with a blood-mimicking water-glycerol mixture (60:40 by volume 
concentration) and circulated using a pulsatile blood pump providing physiologically 
realistic blood-flow waveforms (Fig 3.2.1). 
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Fig 3.2.1 The pulsatile TAAA aneurysm/fenestrated stent model 
 
 
 
A silicone-based, transparent, computed tomography (CT)-reconstructed anthropomorphic phantom representing a 
TAAA aneurysm was used, 5.2 cm in diameter at the visceral segment diameter, with marked aneurysmal 
dilatation of the infra-renal segment (8.1 cm maximum diameter). The phantom was filled with a blood-mimicking 
water-glycerol mixture (60:40 by volume concentration) and circulated using a pulsatile blood pump providing 
physiologically realistic blood-flow waveforms. A four-vessel fenestrated stent graft was constructed and deployed 
in fixed suspension via strings with each fenestration aligned to the corresponding vessel ostia.  
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A four-vessel fenestrated stent graft was constructed from a standard thoracic graft 
(42 mm x10 mm, Medtronic, Santa Rosa, CA). The stent graft was initially deployed 
over the visceral segment (52 mm in diameter) of the transparent phantom; each 
fenestration point was marked in a retrograde fashion from the corresponding target 
vessel. The stent-graft was then removed and four fenestrations reinforced with a 
Prolene suture and radio-opaque markers were constructed in the laboratory: three 
large (12 mm) fenestrations for the right renal, celiac, and superior mesenteric arteries 
and one small (8 mm) fenestration for the left renal artery. The endograft was 
subsequently redeployed in fixed suspension via strings to simulate the partial 
deployment of the Zenith platform. The strings were adjusted to prevent misalignment 
prior to each procedure. 
 
 
Operators 
 
Fifteen operators (eight vascular surgeons, seven interventional radiologists) of 
varying endovascular experience were recruited to participate in the study. They were 
divided into three groups, based on their endovascular procedure experience. Four 
operators had performed 100 to 200 endovascular procedures and had some 
experience in fenestrated stent grafting (< 5); (Group A); five operators had 
performed 200 to 300 endovascular procedures and had moderate experience in 
fenestrated stent grafting (5-15); (Group B); whereas six operators had performed 
over 300 endovascular procedures and had good experience in fenestrated stent 
grafting (>15), carotid stenting, and branch vessel cannulation; (Group C). 
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Study protocol 
 
Each operator was asked to cannulate all four vessels in the fenestrated stent-graft 
aneurysm model, namely the renal arteries, coeliac and superior mesenteric (SMA) 
arteries, under fluoroscopic guidance, using conventional and robotic techniques. A 
range of ten 4 F to 5 F selective catheters and appropriate endovascular guidewires 
commonly used in fenestrated stent grafting were available to all operators. The 
Hansen Sensei System (Hansen Medical, Mountain View, CA) was used for robotic 
catheterization. Operators were randomly assigned to conventional or robotic 
techniques as the first procedure undertaken. Passive intraprocedural support was 
provided by an assistant and a radiographer. Appropriate endovascular tools and a 
range of conventional catheters were selected when asked for, and C-arm orientation 
was changed when requested. 
 
The study protocol included a didactic teaching session regarding the robotic system 
prior to use by each operator. All operators were familiarized with the robotic system 
following a short but standardized training protocol, involving cannulation of the left 
subclavian artery in an aortic arch pulsatile silicon phantom. All procedures were 
performed in the angiography suite and recorded for video assessment. For analysis, 
video footage was blinded, with sound removed, and randomly ordered, identified 
only by an internal coding system. Data from video footage were collected for 
quantitative and qualitative metric analysis.  
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DATA COLLECTION 
 
Quantitative metrics 
 
Total procedure times and times for inserting the catheter into each target vessel from 
the time point the catheter entered the distal end of the graft were measured in 
minutes using a stopwatch. Vessel cannulation was considered satisfactory when the 
catheter was seen in a stable position and at least 3 cm into the target vessel. For those 
operators that were unable to catheterize the vessel in this manner, the final time to 
catheterization of the vessel with a wire was recorded, but not included in the 
cannulation time results. The absolute number of translational (linear displacement 
along a trajectory path) and rotational (circular displacement around a center axis) 
movements at the wire/catheter tip was counted in a binary fashion by two observers 
(C.R, C.B) using blinded-video recordings displaying 2-dimensional fluoroscopic 
data. 
 
 
Qualitative metrics 
 
Performance evaluation was carried out using procedure-specific scoring for vessel 
cannulation, on a 5-point scale: the Imperial College Complex Cannulation Scoring 
Tool (IC3ST), developed specifically for use in these experimental studies. The 
domains tested are specific to vessel cannulation but also rate the procedure as a 
whole and it is derived from the generic Objective Structured Assessment of 
Technical Skills (OSATS) scale validated by the University of Toronto Centre for 
Research in Education [Martin JA et al, 1997; Reznick R et al, 1997]. The IC3ST 
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scale was developed based on the established OSATS scale and previously validated 
and reliable procedure-specific scoring systems used in endovascular skills 
assessment [Hislop SJ et al, 2006; Van Herzeele I et al, 2008; Tedesco MM et al, 
2008; Van Herzeele I et al, 2009] and other medical domains [Friedman Z et al, 2006; 
Aggarwal R et al, 2008].  
 
The scale consists of seven domains with each attributed a score of 1 to 5, with 1 
representing a poor performance, 3 representing a competent performance, and 5 
representing an excellent performance. Descriptive comments for each technical 
domain are given at each of these anchoring points. It grades operators on catheter use 
and manipulation skills, instrumentation, embolization/dissection risk, successful 
vessel cannulation, and overall time, motion, and flow of the procedure. The 
minimum score for technical performance is 7. A score of 21 suggests competence 
and 35 is the maximum attainable score; the higher the score, the better the quality of 
performance. The marking sheet is shown in Fig 3.2.2. Qualitative performance rating 
was carried out by two blinded assessors (C.R and C.B) experienced in the use of 
rating scales. 
 
 
Statistical analysis 
 
Data were analyzed with the Statistical Package for the Social Sciences version 16.0 
(SPSS, Chicago, Ill) using non-parametric tests. Differences between conventional 
and robotic vessel cannulation were compared using the Wilcoxon signed-rank test 
for related samples. Differences between operator groups based on endovascular 
experience using the IC3ST scoring scale (Groups A, B, and C) were assessed using 
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the Kruskal-Wallis test. A p value of less than 0.05 was considered to be statistically 
significant. Inter-observer reliability for blinded assessors was evaluated by 
determining a value for Cronbach’s alpha. It is suggested that for research purposes, a 
reliability coefficient of 0.6 to 0.8 is sufficient, and for a high-stakes assessment, this 
coefficient should be 0.8. The Spearman's rank test was used to correlate quantitative 
metrics (time, movements) with qualitative metrics (operator performance). 
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Fig 3.2.2 The Imperial College Complex Cannulation Scoring Tool (IC3ST) 
 
 
 
The minimum score for technical performance is 7, and 35 is the maximum attainable score. Operators were 
assessed on their ability to choose an appropriate catheter, the ability to recognize catheter unsuitability, use of 
their chosen catheter to its maximum advantage, and the ability to shape and torque the selected catheter with fine 
and controlled movements, as shown on the IC3ST scoring sheet. Embolization/dissection risk was assessed when 
looking at excessive force and multiple catheter tip draggings along the vessel wall and manipulation of the 
guiding catheter without the support of a guide wire, especially in areas of embolic potential, such as the ostia of 
the target vessels. 
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3.3?Results 
 
3.3.1 Quantitative 
 
Whole procedure times: For the whole procedure, median procedure time for 
cannulation of all four vessels was reduced using the robotic system [2.87 min (IQR; 
2.20-3.90) versus 17.24 min (11.90-19.80); p < 0.001; Fig 3.3.1a]. These reductions 
were observed for each individual operator regardless of the level of endovascular 
experience (Fig 3.3.1b). 
 
Movements: The total number of catheter tip movements for the whole procedure was 
also significantly reduced [38 IQR (29-57) versus 454 (283-687); p < 0.001; Fig 
3.3.2a]. Again, reductions in overall procedure movements were observed for each 
individual operator (Fig 3.3.2b), regardless of the level of endovascular experience, 
with a high degree of inter-observer reliability (Cronbach’s α = 0.94). 
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Fig 3.3.1 Whole procedure times 
 
 
 
 
 
 
 
 
 
 
 
 
a. Bar chart representing whole procedure time (minutes) with conventional versus robotic catheters. Median 
procedure times are shown on the y-axis. The error bars represent the interquartile ranges (Wilcoxon signed rank 
test). b. Line chart illustration of the data above showing reductions in median procedure time with the robotic 
system versus conventional techniques, for each individual operator. Each operator is represented as a marker on 
either side of the plot area. 
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Fig 3.3.2 Whole procedure movements 
 
 
 
 
 
a. Bar chart representing whole procedure movements at the wire/catheter tip with conventional versus robotic 
catheters. Median number of movements is shown on the y-axis. The error bars represent the interquartile ranges 
(Wilcoxon signed rank test). b. Line chart illustration of the data above showing reductions in median number of 
wire/catheter movements with the robotic system versus conventional techniques, for each individual operator. 
Each operator is represented as a marker on either side of the plot area. 
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Individual target vessel cannulation times: The median times for catheterization of 
target vessels were 0.36 min IQR (0.20-0.60) for the left renal artery with robotic 
cannulation versus 7.13 min (2.50-8.00) using conventional catheters, 0.79 min (0.70-
1.00) versus 2.76 min (1.90-3.90) for the right renal artery, 1.00 min (0.70-1.30) 
versus 2.26 min (1.30-3.30) for the coeliac artery, and 0.44 min (0.30-0.80) versus 
2.06 min (0.98-6.40) for the SMA (Fig 3.3.3). All differences between conventional 
and robotic techniques were statistically significant (p < 0.001; Fig 3.3.4). 
 
 
Individual target vessel movements: We observed a reduction in the median number 
of movements at the wire/catheter tip taken to complete individual target vessel 
cannulation using the robotic catheter: 5 IQR (3.5-8.5) versus 155 (57-292) for the left 
renal, 10 (7-18) versus 84 (47.5-152) for the right renal artery, 14 (6.5-21.5) versus 62 
(35-100) for the coeliac artery, and 8 (7-14) versus 47 (36-134.5) for the SMA. All 
differences between conventional and robotic techniques were statistically significant 
(p < 0.001, Cronbach’s α 0.94; Fig 3.3.5). 
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Fig 3.3.3 Robotic cannulation of the target vessels 
 
 
 
 
 
 
Fluoroscopic images showing successful cannulation of the renal, SMA and celiac arteries using the robotic 
catheter system.
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Fig 3.3.4 Target vessel cannulation times 
 
 
 
Bar chart representing median individual target vessel cannulation times with conventional versus robotic 
catheters. The error bars represent the interquartile ranges (Wilcoxon signed rank test). 
 
 
Fig 3.3.5 Individual target vessel cannulation movements 
 
 
 
Bar chart representing the median number of wire/catheter tip movements for individual target vessel cannulation 
with conventional versus robotic catheters. The error bars represent the interquartile ranges (Wilcoxon signed rank 
test). 
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3.3.2 Qualitative 
 
Validation of the IC3ST Scale 
 
Construct validity: The IC3ST rating scale successfully differentiated between low 
(Group A: 100–200 endovascular procedures with some experience in fenestrated 
stent grafting, n = 4) and high (Group C: over 300 endovascular procedures with good 
experience in fenestrated stent grafting, carotid stenting, and branch vessel 
cannulation, n = 6) volume intervention groups of endovascular specialists. There 
were significant differences in performance with conventional vessel cannulation 
techniques between operator groups A and C: IC3ST score 15/35 versus 23/35, 
respectively, p = 0.04; Kruskal-Wallis test). There were no differences between 
groups using robotic techniques, demonstrating good construct validity of the IC3ST 
scale. 
 
Correlation between qualitative and quantitative metrics: IC3ST scores showed 
inverse correlations with quantitative metrics (time and movements) for all variables 
but movements with robotic cannulation (Spearman's rank test r) (Table 3.3.1, Fig 
3.3.6).  
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Table 3.3.1 
 
IC3ST Score 
 
 
CORRELATIONS 
 
Time (min) 
 
Mvmts 
 
Conventional  
 
 
r 
 
-0.73 
 
-0.62 
  
p value 
 
0.002 
 
0.01 
 
Robotic           
 
 
r 
 
-0.75 
 
-0.42 
  
p value 
 
0.001 
 
0.12 
 
 
 
 
Fig 3.3.6 Correlations between quantitative and qualitative metrics 
 
 
 
 
IC3ST scores showed inverse correlations with quantitative metrics (time and movements) for all variables but 
movements with robotic cannulation (Spearman's rank test r). 
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Operator performance 
 
Overall performance scores were significantly improved using the robotic system, 
despite minimal operator exposure to this technology [IC3ST score 29/35 IQR (22.8-
30.7) versus 19/35 (13-24.3); p = 0.002, Cronbach’s α 0.85]. IC3ST scores ranged 
from 8 to 29 (maximum, 35) for conventional techniques, with 7 (47%) of the 15 
operators displaying competent performance on this model (Fig 3.3.7). Using the 
robotic system, the IC3ST scores ranged from 19 to 34, with 14 (93%) of the 15 
operators achieving competency, of which 10 (71%) demonstrated performance of a 
very high standard. 
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Fig 3.3.7 Overall operator performance 
 
 
 
 
 
 
Line chart representing individual operator performance scores on the IC3ST scale with conventional and robotic 
cannulation techniques (Wilcoxon signed rank test). Each operator is represented as a marker on either side of the 
plot area. 
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Each group of operators with varying endovascular experience demonstrated an 
improvement in performance with robotic cannulation. For group A, median IC3ST 
score was 28/35 IQR (22-33) versus 15/35 (11-20); p = 0.04; for group B (200-300 
endovascular procedures with moderate experience in fenestrated stent grafting, n = 
5), median IC3ST score was 30/35 (27-31) versus 19/35(18-24); p = 0.07; and for 
group C, median IC3ST score was 28.8/35 (28.5-29) versus 22/35 (16-24); p = 0.06 
(Fig 3.3.8). For groups B and C, these differences did not reach statistical significance 
using non-parametric test analysis for related samples (Wilcoxon signed-rank test). 
One operator in Group B scored 23/35 with robotic cannulation and 29/35 with 
conventional catheters, and one operator in the experienced group C showed no 
change in performance between the two techniques (IC3ST score of 29/35 for both 
conventional and robotic cannulation). All other operators improved their score using 
the robotic technique. 
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Fig 3.3.8 Performance scores according to endovascular experience 
 
 
 
 
 
 
 
 
Bar chart representing operator performance scores between Groups A, B, and C using conventional and robotic 
techniques (Wilcoxon signed rank test). 
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3.4. Discussion 
 
As endovascular procedures for the treatment of aortic disease develop and increase 
in complexity, there is a need to improve technical success, reduce procedure times, 
and minimize fluoroscopic exposure. Fenestrated and branched stent grafts were 
designed to extend the proximal sealing zone from the infrarenal segment to the 
suprarenal and thoraco-abdominal aorta by incorporating the visceral branches.  
 
In recent years, there have been tremendous advancements in the development and 
technology of these devices, with results that compare favorably with those of open 
surgery. Successful results, however, require careful patient selection, appropriate 
custom-made device design, and technical expertise with endovascular grafting, as 
well as visceral vessel cannulation and stenting. The implantation procedure can be 
technically challenging even for experienced operators, especially in the presence of 
difficult anatomy. Vessel tortuosity can cause significant problems with catheter 
control and manipulation, while the presence of thrombus and calcification may lead 
to embolization or dissection with prolonged attempts at target vessel cannulation. 
Graft rotation and misalignment of fenestrations with vessel ostia, due to angulation 
of the more proximal aortic segment, may further prevent easy and safe target vessel 
cannulation. Long fluoroscopic times and radiation exposure to both patients and 
operators are also important concerns. 
 
The success of tackling these adverse effects are largely dependent upon the skill and 
expertise of the operator using manually controlled conventional endovascular 
catheters that may be limited in their maneuverability and torqueability. Remotely 
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steerable robotic endovascular catheters technology may minimize some of these 
challenges by reducing the manual skill required and improving precision and 
stability while potentially reducing the operator’s learning curves. 
 
In this study, robotic cannulation in a pulsatile aneurysm model was significantly 
faster than standard cannulation using conventional endovascular catheters for all 
target vessels. The number of movements at the catheter tip required to complete each 
task was also significantly reduced. This is likely a result of a greater range of motion 
with the robotic catheter and increased three-dimensional control of the catheter tip 
with seven degrees of freedom. With conventional catheters, the operator needs to 
make a series of movements that require adjusting the amount of manual torque in 
order to reach a given target. Some advocate, that during fenestrated endografting, the 
superior mesentery and coeliac arteries are more easily catheterized via a brachial 
approach. In this study, the femoral approach was used successfully in all 
catheterizations. Clearly, the current size of the robotic catheter would not be suitable 
for a brachial approach; however, the improved maneuverability and stability of the 
device may allow cannulation of visceral vessels through femoral access.  
 
A limitation of other robotic and remote catheter control systems is the lack of 
mechanical feedback that the operator receives from manual catheter manipulation, 
and hence the ability to assess the amount of force that is being applied to the target 
tissues. With the Da Vinci robotic system in laparoscopic surgery, the operator is able 
to assess tissue deformation through direct visualization. One possible method of 
overcoming this in an endovascular setting reliant on fluoroscopic views is 
Intellisense Fine Force Technology incorporated within the Hansen robotic system, 
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which allows for visual and haptic feedback of the force applied to the catheter tip, 
thereby improving the safety of the device. Another limitation of the Hansen system 
is that it requires access via a 14 F sheath. If a four-vessel fenestrated stent graft 
procedure was to be undertaken via the femoral approach, four 7 F guide-sheaths 
would have to be inserted via a single common femoral artery. At present, 
simultaneous access to all four vessels can only be achieved by placing stiff 
guidewires using the robotic catheter and then subsequently placing guiding sheaths 
via the conventional approach. Further development of the robotic system is certainly 
mandated for optimal use in endovascular therapy. 
 
Other factors such as operator and staff training, set-up times, overall cost, and system 
maintenance should also be taken into consideration. Set-up times in this study varied 
from 5 minutes to 15 minutes on average for each procedure. This can be seen as a 
drawback if one considers the set-up times for conventional catheters to be negligible; 
however, the potential advantage of faster target vessel cannulation and stability at 
sites of interest while accommodating other endovascular catheters, stiff wires, and 
side-branch stents may reduce procedure times as a whole, despite longer set-up 
times. The adoption of this new technology would certainly be more widespread if it 
can be shown to reduce procedure times, without significant increase in cost. An 
analysis regarding the cost-effectiveness of this system is beyond the remit of this 
thesis; cost can only be balanced out if this device is shown to reduce procedure times 
and improve accuracy in complex endovascular procedures such as fenestrated stent 
grafting in large patient series within a clinical setting. 
 
Overall IC3ST performance scores were significantly improved using the robotic 
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system, and the majority of subjects demonstrated performance of a high standard, 
despite minimal exposure to this novel technology, demonstrating ease of use and its 
intuitive nature. Subgroup analysis revealed that, for the less experienced group A, 
performance scores were significantly improved with robotic cannulation. For groups 
B and C, these differences did not reach statistical significance using non-parametric 
test analysis for related samples (Wilcoxon signed-rank test), and this is not 
surprising, as, with any new device, there is a learning curve to its use. This may also 
be attributed to the relatively small sample size of the three groups. It is worth noting, 
however, that for highly experienced interventionalists (group C), IC3ST scores were 
high for conventional cannulation, and similar scores were attained using the robotic 
system even with short training times. Experienced operators may attain even higher 
scores with further training on the robotic system. The less experienced groups 
reached the same high standard as group C operators using robotic technology, which 
may impact on training and learning curves in the future. 
 
One of the most obvious advantages of a remote-controlled catheter system is the 
negligible fluoroscopy exposure for the operator, as the workstation is located in the 
control room of the angiography suite and away from the radiation source. Although 
this study does not allow for a direct representation of the potential for this 
technology to reduce radiation exposure to patients, one can foresee the effect on 
patient exposure resulting from overall reduction in fluoroscopic times. The Hansen 
system is also compatible with existing non-fluoroscopic mapping systems such as 
CARTO (Biosense Webster Inc, Diamond Bar, CA) and NavX (St. Jude Medical, St. 
Paul, MIN). Enhanced integration of robotics with 3D navigation technology may 
further improve the accuracy of catheter positioning and manipulation that is of 
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paramount importance in fenestrated stent grafting. In addition, use of this system 
may limit the fatigue associated with prolonged complex endovascular procedures, as 
the operator can remain seated at the remote workstation, and thus further enhance 
operator performance. 
 
This study is limited by the use of an in vitro pulsatile silicon phantom and does not 
totally reflect the challenges of navigating within the human aorta in a clinical setting. 
To explore this further, we have initiated a trial, approved by our Institution and the 
Regional Ethics Committee, to assess the feasibility of using this robotic technology 
in vivo and determine its safety and performance in clinical cases of fenestrated stent 
grafting.  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3.5. Conclusions 
 
These results demonstrate that robotic catheterization of target vessels during 
fenestrated stent grafting in a pulsatile flow model is feasible with negligible radiation 
exposure for the operator. Vessel cannulation times are reduced using robotic 
technology with significant reduction in the number of movements compared with 
conventional cannulation techniques. Steerable robotic catheters with intuitive control 
may overcome some of the limitations of standard catheter technology in the human 
vascular tree, enhance target vessel cannulation, reduce instrumentation, and improve 
overall performance scores. Further studies into the use of this technology in a clinical 
setting will be important in evaluating this system for use in complex endovascular 
procedures.   
 
 
 
 
 
 
 
 
 
 89 
Chapter 4. 
Endovascular robotics for arch vessel 
cannulation 
 
4.1?Background 
One of the major concerns of advanced endovascular carotid intervention as seen in 
carotid artery stenting (CAS) has been the potential to produce embolic particles that 
may manifest as neurologic deficits [DeMonte F et al, 1989; Ohki T et al, 1998; 
McPhee J et al, 2009]. Stroke resulting from cannulation of the great vessels during 
CAS cannot be prevented by current protection systems. In an analysis of 627 
protected CAS procedures, Verzini et al documented 10 major strokes and 1 cardiac 
death; 4 major strokes occurred during the cannulation phase involving the arch 
vessel origin or the common carotid artery (CCA) itself [Verzini F et al, 2006]. There 
is considerable evidence, both experimental and clinical with Transcranial Doppler 
(TCD) and diffusion-weighted magnetic resonance imaging (DW-MRI), that 
microembolization during CAS takes place throughout all stages of the procedure 
[Coggia M et al, 2000; Bicknell CD et al, 2003; Blasel S et al, 2009; Vos JA et al, 
2009; Bonati LH et al, 2010]. The excess risk of peri-procedural neurological 
complications observed during advanced endovascular intervention in the arch seems 
to be multifactorial: poor patient selection, carotid plaque morphology, tortuosity, 
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angulation and complex aortic arch anatomy (bovine or Type III arch variants), device 
technology and operator experience, all play an important role.  
 
In order to improve clinical outcomes by reducing cerebral embolization rates and 
hence the risk of stroke, the above factors must be targeted. In recent years, improved 
patient selection and increased operator experience have facilitated complex 
intervention in the arch. Further technical refinements, however, may also be 
essential. Efficient stable sheath placement in the CCA is a crucial determinant of 
technical success, to avoid significant embolization from the aortic arch and the CCA 
as well as ensure a stable platform for introduction of endovascular tools into the 
internal carotid artery (ICA). The purpose of this study was to investigate whether 
arch vessel cannulation can be enhanced by a remotely-steerable robotic catheter 
system. The study compared robotic and conventional catheters with respect to time 
and accuracy of vessel cannulation, potential risk of embolization and overall operator 
performance using pulsatile silicone phantoms.  
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4.2?Methodology 
 
Aortic Arch models 
 
There are three types of aortic arches, based on the relationship of the innominate 
artery to the arch itself [Casserly IP et al, 2005; Bates ER et al, 2007]. The type I 
aortic arch is characterized by the origin of all 3 great vessels being in the same 
horizontal plane as the outer curvature of the aortic arch (Fig 4.2.1a). In the type II 
aortic arch, the innominate artery originates between the horizontal plane of the outer 
and inner curvatures of the arch. In the type III aortic arch, the innominate artery 
originates below the horizontal plane of the inner curvature of the arch (Fig 4.2.1b). 
The more inferior the origin of the target artery (i.e. type II or III aortic arch), the 
greater the difficulty in gaining access to the carotid artery with a higher the risk of 
distal embolization or dissection [Balzer JO, 2008].  
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Fig 4.2.1 Type I (A) and Type III (B) aortic arches  
 
 
 
 
A: a type I arch is characterized by the origin of all 3 great vessels being in the same horizontal plane as the outer 
curvature of the aortic arch. B: a type III aortic arch, with the innominate artery originating below the horizontal 
plane of the inner curvature of the arch. 
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In addition to the type of arch, the configuration of the great vessels is also important. 
In the standard anatomical configuration, the innominate artery, the left CCA, and the 
left subclavian artery have separate origins from the arch. Two common anomalies 
are encountered in clinical practice, both of which have been termed ‘bovine arches’. 
The first variant involves a common origin to the innominate artery and the left CCA. 
The second common anomaly involves the left CCA arising as a branch of the 
innominate artery. Both of these variants can also cause access difficulties.  
 
To assess the efficacy of robotic arch vessel cannulation, two silicone-based, 
transparent, CT-reconstructed anthropomorphic phantoms (Elastrat Sàrl, Geneva, 
Switzerland) were used representing: 
 
a) A Type I aortic arch with bovine configuration of the left CCA  
b) A Type III aortic arch 
 
The phantoms were filled with a blood-mimicking water-glycerol mixture (60:40 by 
volume concentration) and circulated using a pulsatile blood pump providing 
physiologically realistic blood-flow waveforms (Fig 4.2.2). Arch vessel calibre varied 
between 6mm and 7 mm in diameter. 
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Fig 4.2.2 The pulsatile aortic arch phantoms 
 
 
 
Fluoroscopic images of the two silicone-based, transparent, CT-reconstructed anthropomorphic phantoms 
representing the Type I and Type III aortic arches are shown. The phantoms were filled with a blood-mimicking 
water-glycerol mixture (60:40 by volume concentration) and circulated using a pulsatile blood pump providing 
physiologically realistic blood-flow waveforms. 
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Operators 
 
Seventeen operators (nine vascular surgeons, seven interventional radiologists, one 
cardiologist) of varying endovascular experience were recruited to participate in the 
study. They were divided into three groups, according to their endovascular 
experience. Five operators had performed less than a 100 endovascular procedures 
and had minimal experience with CAS (0-2); (Group A), six operators had performed 
100 - 300 endovascular procedures and had some experience with CAS (2-5); (Group 
B), whereas six operators had performed over 300 endovascular procedures and had 
moderate to extensive experience with CAS (5-70); (Group C). 
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Study protocol 
 
Each operator was asked to cannulate the left subclavian (LSA), left common carotid 
(LCCA), right subclavian (RSA) and right common carotid (RCCA) arteries of the 
arch phantom, under fluoroscopic guidance, using conventional and robotic (Hansen 
Sensei) techniques. Operators were randomly assigned to conventional and robotic 
techniques, as well as the type of arch used as the first procedure undertaken. All 
operators underwent a short, standardized didactic teaching session on the robotic 
system before commencing the study followed by a practical demonstration and 
training session. Passive intra-procedural support was provided by an assistant and a 
radiographer. Appropriate endovascular tools, including wires and a range of ten 
conventional 4 F to 5 F shaped catheters commonly used in CAS were available and 
C-arm orientation was adjusted as requested by the operator. All procedures were 
performed in the angiography suite and recorded for blinded video assessment of 
quantitative and qualitative metrics. 
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DATA COLLECTION 
 
Quantitative metrics 
 
Ease of vessel cannulation - time and accuracy 
 
Arch vessel cannulation times from the point the catheter entered the distal part of the 
descending aorta was measured in minutes using a stopwatch. Vessel cannulation was 
considered satisfactory when the catheter followed the wire at least 3 cm into the 
target vessel. For those operators that were unable to catheterize the vessel in this 
manner the end time to successful access to the vessel with a wire was recorded with 
a wire was recorded, but not included in the cannulation time results. The absolute 
number of translational (linear displacement along a trajectory path) and rotational 
(circular displacement around a center axis) movements at the wire/catheter tip was 
counted in a binary fashion by two observers (C.R and C.B) using blinded-video 
recordings displaying 2-dimensional fluoroscopic data. 
 
Embolization risk 
 
The number of times the catheter tip came into contact with the vessel wall (wall hits) 
at the ostium of the common carotid artery (CCA) and at the aortic arch from the 
aortic valve to the LCCA origin was also counted in a binary fashion by two 
observers (C.R and C.B) using blinded-video recordings displaying 2-dimensional 
fluoroscopic data displaying the outline of the aortic arch and the target vessels. 
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Qualitative metrics 
 
Operator experience and performance 
 
Performance evaluation was carried out using the IC3ST scale described in the last 
chapter (Chapter 3). Qualitative performance rating was carried out by two blinded 
assessors (C.R and C.B).  
 
 
Statistical analysis 
 
The Statistical Package for the Social Sciences version 16.0 (SPSS, Chicago, Ill., 
USA) was used for data analysis. The non-parametric distribution of the data 
necessitated the use of non-parametric tests for significance. Differences between 
conventional and robotic arch vessel cannulation were compared using the Wilcoxon 
signed-rank test for related samples.  
 
Differences between operator groups based on endovascular experience using the 
IC3ST scoring scale (Groups A, B and C) were assessed using the Kruskal-Wallis test 
and post-hoc analysis with Mann-Whitney U test. The Spearman's rank test was used 
to correlate quantitative metrics (time, movements, wall hits) with qualitative metrics 
(operator performance). A p value of p < 0 .05 was considered statistically significant. 
Inter-observer reliability for the blinded assessors was calculated with the Cronbach's 
alpha test statistic. 
 
 
 99 
 
4.3?Results 
 
4.3.1 Quantitative 
 
Ease of vessel cannulation - time and accuracy 
 
Arch vessel cannulation times (Fig 4.3.1) - 2/17 operators failed to cannulate the 
RCCA in the Type III arch using conventional catheters in a satisfactory manner as 
described in the methods section i.e. with the catheter following the wire at least 3 cm 
into the target vessel in a stable position. For the remaining 15 subjects median times 
for cannulation of the carotid arteries were significantly reduced using the robotic 
catheter system for both types of arches: Type I arch: LCCA 2.70min IQR (1.92-3.98) 
versus 0.80min IQR(0.30 -1.57) p=0.001, RCCA 1.70min (1.20-3.35) versus  0.69min  
(0.44-0.99) P=0.001; Type III arch: LCCA 3.78min (0.92-11.28) versus 1.02min 
(0.61-2.10) p=0.01, RCCA 6.2min (3.02-8.97) versus  1.81min (0.67-3.02) p=0.001. 
The median cannulation times for the LSA in the Type I arch were also significantly 
reduced LSA 0.76min (0.34-0.88) versus 0.25min (0.18-0.31) p=0.002. 
 
Movements (Fig 4.3.2) - The median number of catheter tip movements for individual 
arch vessel cannulation was significantly reduced for all vessels with robotic 
catheterization techniques for both Type I and Type III arches: Type I arch: LSA 18 
(14-31) versus 7 (6-10) p=0.001, LCCA 61 (51-165) versus 9 (7-25) p=0.001, RSA 
22 (15-48) versus 11 (8-15) p=0.005, RCCA 48 (21-81) versus 9 (6-10) p=0.001; 
Type III arch: LSA 24 (17-38) versus 7 (6-11) p=0.001, LCCA 89 (45-284) versus 14 
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(12-21) p=0.001, RSA 69 (48-81) versus  31 (16-42) p=0.003, RCCA 209 (124-335) 
versus 30 (9-38) p=0.001. Inter-observer reliability between observers was calculated: 
Cronbach’s α =0.85, indicating a good degree of agreement. 
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Fig 4.3.1 Arch vessel cannulation times 
 
Bar chart representing median individual arch vessel cannulation times with conventional versus robotic catheters, 
in the Type I (first two bars from left to right) and Type III (last two bars from left to right) arches. The error bars 
represent the interquartile ranges (Wilcoxon signed rank test). 
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Fig 4.3.2 Catheter movements in the arch model 
 
 
Bar chart representing median number of movements for each individual arch vessel cannulation with 
conventional versus robotic catheters, in the Type I (first two bars from left to right) and Type III (last two bars 
from left to right) arches. The error bars represent the interquartile ranges (Wilcoxon signed rank test). 
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Embolization risk 
 
Wall Hits (Fig 4.3.3) - Vessel wall contact with the aortic arch wall was reduced to a 
median of zero with robotic catheterizations. CCA ostium contact still took place, but 
was significantly reduced. Median catheter tip vessel wall hits were: Type I Arch: 2 
IQR (1.5 – 13) versus 0(0-0); p=0.001 for the aortic arch and 4.5 (3.5 – 11.3) versus 2 
(1.5 - 3.5); p=0.001 for the CCA origin, and Type III Arch: 13.8 (9.5 -19) versus 0.5 
(0.3 – 1.5); p=0.001 for the aortic arch and 9 (5 -21.5) versus 5 (4 -9); p=0.04 for the 
CCA origin (inter-observer reliability: Cronbach’s α 0.82). 
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Fig 4.3.3 Wall hits during arch vessel cannulation 
 
Bar chart representing median number of wall hits during carotid artery cannulations in the aortic arch proximal to 
the CCA and at the carotid ostium, with conventional versus robotic catheters, in the Type I (first two bars from 
left to right) and Type III (last two bars from left to right) arches. The error bars represent the interquartile ranges 
(Wilcoxon signed rank test). 
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4.3.2 Qualitative 
 
The IC3ST rating scale successfully differentiated between low (Group A) and high 
(Group C) volume intervention groups of endovascular specialists in the Type I arch 
(IC3ST score 20/35 IQR (16 -28) versus 30.9/35 (27.6 -32.5) respectively; Mann-
Whitney U test, p= 0.02), and between all three groups in the more technically 
challenging Type III arch (IC3ST score Group A: 14.5/35 (13 -16.5), Group B: 
19.3/35 (16.9 – 22), Group C: 26.8/35 (25 -29.6); Kruskal-Wallis test, p=0.03). There 
were no differences between groups using the robotic system (inter-observer 
reliability: Cronbach’s α 0.94). 
 
Correlation between qualitative and quantitative metrics: IC3ST scores showed 
inverse correlations with many of the quantitative metrics (times, movements, wall 
hits) (Spearman's rank test r) (Table 4.3.1, Fig 4.3.4).  
 
Table 4.3.1 
 
IC3ST Score 
 
 
CORRELATIONS 
 
Time (min) 
 
Mvmts 
 
Wall Hits 
Conventional  
Type I Arch 
r -0.67 -0.57 -0.75 
 p value <0.01 0.02 <0.01 
Robotic           
Type I Arch 
r 0.49 0.17 -0.59 
 p value 0.04 0.52 0.01 
Conventional  
Type III Arch 
r -0.63 -0.48 -0.85 
 p value <0.01 0.04 <0.01 
Robotic           
Type III Arch 
r -0.50 0.13 -0.49 
 p value 0.04 0.63 0.04 
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Fig 4.3.4 Correlations between quantitative and qualitative metrics 
 
 
 
 
 
 
 
 
IC3ST scores showed inverse correlations with many of the quantitative metrics (times, movements, wall hits) 
(Spearman's rank test r). 
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Operator performance 
 
Overall performance scores were significantly improved using the robotic system: 
  
Type I Arch: IC3ST score 26/35 IQR (20 -30.8) versus 33/35 (31 -34); p=0.001. 
88.2% (15/17) of operators improved their scores using the robotic catheter system. 
With conventional cannulation, IC3ST scores ranged from 10 to 34, with 76.5% 
(13/17) of operators demonstrating competence in this model. Robotic cannulation 
scores ranged from 29 to 34.5, with all 17 operators achieving high-standard 
performance scores. 
 
Type III Arch: IC3ST score 20.5/35 IQR (16.5-28.5) versus 26.5/35 (23.5 -28.8); 
p=0.001. 70.6% (12/17) of operators improved their scores using the robotic catheter 
system. Scores ranged from 12.5 to 34 with conventional techniques, and a mere 47% 
(8/17) of operators (8/17) demonstrated competence in the angulated aortic arch, 
whereas with robotic techniques, IC3ST scores ranged from 17 to 30, and 82.4% of 
the operators attained performance scores at the high-end of the IC3ST scale. 
 
Low and medium volume interventionalists (Groups A and B) demonstrated an 
improvement in performance with robotic cannulation techniques. In the high volume 
intervention group (Group C), there was no statistically significant improvement in 
performance; however, all operators obtained high scores irrespective of the 
cannulation method used and completed the task faster, with fewer movements and 
wall hits using the robotic system. Operator performance results are shown in Figures 
4.3.5 and 4.3.6. 
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Fig 4.3.5 Performance scores in the Type I Arch 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.3.6. Performance scores in the Type III Arch 
 
 
 
 
 
Bar charts representing operator performance IC3ST scores in the Type I and Type III arches respectively between 
Groups A, B, and C using conventional and robotic techniques (Kruskal-Wallis and Wilcoxon signed rank tests). 
The line chart in the top right corner of each graph represents individual operator performance scores; each 
operator is represented as a marker on either side of the plot area. 
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4.4. Discussion 
 
Accurate navigation through the aortic arch and stability of the wires and catheters 
during the procedure is of vital importance to reduce cerebral embolization and risk of 
stroke. Endovascular robotic technology may provide a useful adjunct to overcome 
some of the challenges of complex endovascular intervention in this setting. This 
chapter investigates whether use of a robotic catheter system can enhance the 
technical skill required in cannulation of the great vessels in complex arch anatomy, 
improve positional precision and stability, as well as operator performance. 
 
Complex anatomy 
 
Severe atherosclerosis of the aortic arch, tortuosity and extreme angulation of the 
great vessels (Type III arch) may prohibit straightforward catheterization, 
compromising catheter stability and the safety of the procedure, as highlighted in the 
Delphi Consensus statement [Macdonald S et al, 2009]. A very acute angle of the 
origin of the CCA off the aortic arch may result in unsuccessful vascular access, 
technical errors and overall technical failure. Vascular access may be even more 
challenging with bovine arch variants potentially exposing the patient to longer 
catheter manipulation and therefore potentially higher risk of embolization. The 
association between aortic arch anomalies and procedural risk has been explored in 
214 consecutive patients; technical failure was higher and neurological complications 
occurred more frequently in the arch anomaly group (20% versus 5.3%, p=0.039); the 
type of aortic arch was the only variable independently associated with neurological 
complications (odds ratio=2.01, p=0.026) [Faggioli G et al, 2007]. In our study, 
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robotic cannulation of the CCAs was significantly faster than standard cannulation 
using conventional endovascular catheters. The number of movements at the catheter 
tip as well as the median catheter tip vessel wall hits were also significantly reduced. 
Although a degree of carotid ostium wall contact still takes place, use of the robotic 
catheter system virtually eliminates the number of wall hits in the arch, proximal to 
the CCAs. More importantly, the greatest differences were observed in the most 
challenging Type III arch and bovine configurations, which may reflect the improved 
maneuverability, torquability and stability of the robotic device.  
 
 
Technological limitations of current techniques 
 
The risk of embolization is thought to be proportional to the number of endovascular 
manipulations in the aortic arch and supra-aortic vessels; apart from complex 
anatomical factors, excessive instrumentation in the arch can also be due to 
suboptimal catheter selection or functionality [Schlüter M et al, 2003]. Conventional 
double-curve catheters pose an even greater risk of vessel wall trauma and 
embolization as they can be challenging to shape and rotate in the presence of a 
tortuous aortic arch or an unfavorable supra-aortic takeoff [Chang FC et al, 2009]. A 
general guideline to minimize excessive manipulation is the “3-15” rule: avoid using 
more than 3 catheters or spending more than 15 minutes in each cannulation attempt 
[Veeraswamy RK et al, 2007]. A common strategy employed by many 
interventionalists especially in tortuous and angulated arches, involves advancing a 
curved endovascular catheter in the ascending aorta first before withdrawing the 
catheter along the outer wall of the aortic arch until it engages the target vessel origin. 
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This technique inevitably increases the risk of embologenic sequelae especially in 
atherosclerotic arches. A robotic catheter system allows the operator to shape the 
catheter tip and follow the curve of the selected vessel or trajectory path with greater 
precision and accuracy, avoiding the need for the technique described above or 
repeated manipulations near the CCA origin whilst allowing for centerline navigation 
with minimal contact with the vessel wall. Furthermore, during robotic cannulations, 
we observed that the configuration of the robotic catheter remained unchanged on 
release of the 3D joystick, offering an additional functional advantage in terms of 
positional control and stability.  
 
Operator Experience 
 
With the introduction of CAS, a broad variety of ‘‘carotid interventionalists’’ has 
emerged. The Society for Vascular Surgery has published minimal catheter and guide 
wire skills performance guidelines for interventional procedures [White RA et al, 
1999], but has not as yet defined the minimal requirements necessary for the 
performance of CAS, not only in terms of advanced technical skills but also clinical 
judgment in terms of patient selection and timing of intervention. The choice of 
technique in particular, is largely operator dependent and a number of clinical reports 
have highlighted the importance of the operator’s experience as a crucial factor in the 
clinical success [Ahmadi R et al, 2001; Lin PH et al, 2005; Verzini F et al, 2006; 
Theiss W et al, 2008]. A peri-procedural stroke-death rate of 5.9% is seen at centers 
with <50 interventions, whereas at centers with >150 cases, the stroke-death rate is 
significantly lower (3.0%) [Theiss W et al, 2008]. Verzini et al. observed a significant 
learning curve in operator experience: from a 3.1% 30-day major stroke-death rate 
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during the initial 195 protected CAS procedures to a 0.9% for 432 procedures over a 5 
year period, along with reductions in procedure times and contrast volume used 
[Verzini F et al, 2006]. This learning curve effect has also been demonstrated by other 
centers [Lin PH et al, 2005] as well as RCTs such as the EVA-3S trial where the 
unacceptably high 9.6% 30-day stroke-death rate reported, may have been attributable 
to the fact that as few as five CAS procedures was the prerequisite for the participants 
[Mas JL et al, 2008].  
 
In our study, despite minimal exposure of the operators to robotic endovascular 
technology and short training times, we observed a global improvement in 
quantitative metrics (times/movements/wall hits) and overall performance scores 
using the IC3ST scale with the robotic system irrespective of the operators 
endovascular experience, even in the more technically challenging tortuous aortic 
arch and bovine anatomy. Subgroup analysis revealed that the less experienced 
groups A and B, obtained scores at the high-end of the IC3ST scale, demonstrating 
the same high-standard performance as highly experienced interventionalists (group 
C). This may have important implications on training and learning curves for complex 
endovascular procedures in the clinical setting. In the high volume intervention group 
(Group C), there was no statistically significant improvement in performance; these 
operators obtained high performance scores irrespective of the cannulation method 
used but completed the task faster and with significantly fewer movements and wall 
hits. These findings highlight ease of use and the intuitive nature of this robotic 
technology. The scores obtained by experienced operators in our study reflect years of 
experience in using conventional endovascular catheters versus a short introductory 
session to the robotic system. These operators, therefore, may attain even higher 
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scores and improve their performance even further with subsequent training.  
 
One of the most obvious advantages of remote-controlled robotic technology is the 
negligible fluoroscopic operator exposure, as the robotic workstation is located away 
from the radiation source. Although not directly represented in this study, radiation 
exposure for the patient may also be reduced from faster cannulation, secure vessel 
access and therefore overall reduction in fluoroscopic times. 
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Limitations 
 
Wider access via the common femoral artery and alterations in the anatomy of the 
bifurcation are some of the disadvantages of using a co-axial system.  Careless 
advancement of the sheath can also result in vessel dissection. Clearly the current size 
of the robotic catheter that requires access via a 14F sheath would not be suitable for a 
brachial approach, and the 11F inner guide is still too large to allow confident 
advancement into the CCA in a clinical setting. The ability, however, to place the 
robotic tip in a stable position just at the origin of the CCA is an obvious advantage.  
The current robotic device was manufactured for use in the heart via a transvenous 
approach. Further development of this robotic technology and a lower-profile device 
is certainly mandated for optimal use in advanced carotid and arch vessel 
intervention. 
 
Other factors such as set-up times, overall cost and system maintenance must also be 
considered. No advantage was seen during simple tasks; cannulation of the subclavian 
arteries for instance and therefore routine use of the system for straightforward 
intervention would not be cost-effective. Finally, our study is limited by the use of in-
vitro phantoms, as these experimental models do not reflect all the challenges of 
catheter navigation in atherosclerotic aortic arches and the carotid bifurcation within a 
clinical setting. In addition, the metrics used in this study are surrogate markers of 
embolization risk and technical performance, and are in no means a substitute to 
clinical endpoints; they do however provide us with a reliable estimate of technical 
skill in catheter and wire manipulations.  
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4.5. Conclusions 
 
Cerebral embolic events and the risk of stroke constitute the most challenging 
problem in advanced endovascular intervention in the arch, and the predisposing 
factors have been discussed in this chapter. The results demonstrate that robotic 
technology has the potential to reduce the time, risk of embolization, radiation 
exposure and the manual skill required for carotid cannulation and stenting, whilst 
improving overall operator performance scores with minimal training. With advances 
in technology and imaging and the availability of dedicated equipment, better 
understanding of patient selection and timing of intervention current results are likely 
to be enhanced. Further studies utilizing this intuitive technology in the clinical 
environment are essential for evaluating its long-term safety and efficacy. 
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Chapter 5. 
Endovascular catheter stability  
 
5.1?Background 
 
Mere target vessel catheterization does not necessarily reflect technical success in 
complex endovascular intervention. Equally important is the ability to advance stiff 
guidewires and other endovascular tools whilst maintaining stability at target sites. 
Stable catheter positioning is of paramount importance and particularly challenging 
when the path to the target vessel ostium consists of multiple bends in different 
planes. Exchanging a selective catheter over a stiff guidewire in a telescoping fashion 
is the standard maneuver to position a guide catheter into the target vessel.  Tortuous 
and angulated arterial anatomy poses significant problems, and buckling or herniation 
of the guiding catheters back into the aorta frequently occurs threatening vessel 
access. This results in repeated cannulation attempts that contribute to the long 
fluoroscopic times seen in fenestrated endografting procedures and the increased risk 
of embolization during arch vessel intervention as highlighted in previous chapters. 
 
In this chapter, we aimed to investigate the stability of the robotic catheter system 
during stiff-guidewire exchanges in the carotid and renal arteries in direct comparison 
with conventional endovascular catheter techniques. 
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5.2?Methodology 
 
Aortic Model 
 
A silicone-based, transparent, CT-reconstructed anthropomorphic phantom (Elastrat 
Sàrl, Geneva, Switzerland) was used, formed by combining two of the models 
described in previous chapters:  the Type I aortic arch with bovine configuration of 
the LCCA (Chapter 4) and the TAAA aneurysm with a 5.2 cm dilatation of the 
visceral segment and a 8.1cm dilatation of the infra-renal segment (Chapter 3). The 
phantom was filled with a blood-mimicking water-glycerol mixture (60:40 by volume 
concentration) and circulated using a pulsatile blood pump providing physiologically 
realistic blood-flow waveforms as previously described. 
 
Study protocol 
 
A single experienced operator cannulated the renal and carotid arteries (4 vessels in 
total) using standard-Terumo wires, which were then exchanged for 0.035-inch stiff-
guidewires under fluoroscopy, using robotic and conventional catheters. Exchanges 
took place at 3 distinct points, with the catheter-tip at: 4cm (Point-A), 2cm (Point-B) 
and 0cm (Point-C) from the target vessel ostium. Each task was repeated three times. 
Five commonly used, conventional catheters were tested. Two hundred and sixteen 
stiff-guidewire exchanges in total were recorded for video-assessment. Catheter tip 
deflection from each point during guidewire exchanges (distance in cm) was 
measured in a 2-dimensional plane using the recorded digital images.  
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Statistical analysis 
 
The Statistical Package for the Social Sciences version 18.0 (SPSS, Chicago, Ill., 
USA) was used for data analysis. The degree of catheter tip deflection for robotic 
versus conventional techniques was analyzed using the Mann-Whitney U test. 
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5.3?Results 
 
In 216 stiff guidewire exchanges studied, robotic endovascular catheters maintained 
stability at target sites with zero deflection during stiff guidewire exchanges, 
independent of the distance the catheter was introduced into the target vessel. Median 
conventional catheter deflection was as follows:  
 
Carotid arteries: point-A (4cm into the vessel), 0cm IQR (0-0); point-B (2cm into 
vessel), 0cm(0-4.5) with complete loss of access (LOA) in 16.7% of cases; point-C (at 
the CCA origin), 7cm(1.3-9.8) with complete LOA in 50% of cases (Fig 5.3.1, Fig 
5.3.2).  
 
Renal arteries: point-A, 0cm(0-0.3); point-B, 4.5cm(1.8-7) with LOA in 25% of 
cases; point-C (the renal ostium), 5cm(4.3-5) with LOA in 62.5% of cases (Fig 5.3.3, 
Fig 5.3.4). 
 
No statistically significant differences between robotic and conventional catheters 
were observed for point-A during renal cannulations (p=0.21) and points A and B 
during carotid cannulations (p=0.47). Robotic catheters however, demonstrated 
increased stability at points B for the renal arteries (p=0.005) and point C (i.e. the 
target vessel ostium) for both the renals and the CCAs (p=0.005 and p=0.03 
respectively). 
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Fig 5.3.1  
Catheter stability during stiff guidewire exchanges in the arch (LCCA) 
 
 
 
Stiff guidewire exchanges during cannulation of the LCCA with conventional (bottom row) and robotic (top row) 
techniques are shown. Exchanges took place at 3 distinct points, with the catheter-tip at: 4cm (Point-A), 2cm 
(Point-B) and 0cm (Point-C) from the carotid artery ostium. 
 
 
Fig 5.3.2 Loss of carotid artery access during stiff guidewire exchanges 
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Fig 5.3.3  
 
Catheter stability during stiff guidewire exchanges in the visceral segment (R 
renal artery) 
 
 
 
 
Stiff guidewire exchanges during cannulation of the right renal artery with conventional (top row) and robotic 
(bottom row) techniques are shown. Exchanges took place at 3 distinct points, with the catheter-tip at: 4cm (Point-
A), 2cm (Point-B) and 0cm (Point-C) from the renal artery ostium. 
 
 
Fig 5.3.4 Loss of renal artery access during stiff guidewire exchanges 
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5.4. Discussion 
 
 
 
Adequate guide catheter positioning and support remains one of the leading 
challenges for peripheral arterial interventional procedures. Because of the 
unpredictable anatomy often encountered in complex cases, including excessive 
vessel tortuosity and acute angulation of the aortic bifurcation, which may not 
accommodate the use of conventional over-the-top guiding sheaths, suboptimal guide 
catheter support may contribute to prolonged instrumentation, unsatisfactory side-
branch device deployment and embologenic sequelae [White CJ et al, 1991; 
Rundaback JH et al, 2001; Kandzari DE et al, 2003].   
 
The use of either a guiding catheter or a long sheath is a prerequisite in arch vessel 
cannulation procedures and CAS; the inability to position a guiding catheter or a 
sheath near the carotid bifurcation is one of the main reasons for CAS failure. 
Exchanging a diagnostic catheter over a stiff guidewire in a telescoping fashion is the 
standard maneuver to position the guide catheter in the CCA. For tortuous vessels, the 
wire is positioned very distally in the external carotid artery (ECA), to allow a stable 
exchange. This technique may not be sufficient for a very acute angle of the CCA off 
the aortic arch and even when a 5F diagnostic catheter has been placed in the ECA, 
the introduction of a stiffer exchange guidewire usually pulls the catheter out of the 
vessel with the entire system herniating back into the arch. In cases that require a 
more aggressive guiding catheter shape and the tip of the guide cannot be positioned 
in the distal CCA, just below the carotid bifurcation, then it is usually positioned in 
the proximal CCA, which generally provides less support for the procedure, and may 
result in loss of access and multiple cannulation attempts.  
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To overcome some of these technical issues, several techniques and modifications 
have been proposed such as “steaming” the tip of the guiding catheter in order to 
reshape it [Houdart E et al, 2001], using microcatheters to stabilize the guidewire 
during manipulation [Van den Berg JC et al, 2002], and anchoring a stiff guidewire in 
the right brachial artery as support, in order to advance the guiding catheter up to the 
right subclavian artery and the CCA bifurcation [Gupta K et al, 2008].  If these 
maneuvers prove to be unsuccessful, then a direct carotid artery puncture or a 
transbrachial approach as a salvage technique can be considered if the patient's risks 
for CEA are unacceptably high. It has been proposed that up to 26% of CAS 
procedures require advanced technical skill and a modification in the standard 
technique for successful outcomes [Choi HM et al, 2004]. 
 
Conventional catheter instability can also compromise effective target vessel 
cannulation in the visceral segment in branched and fenestrated stent grafting 
procedures. Even small degrees of misalignment at the fenestration/target vessel 
ostium interface can make passing a catheter directly through the fenestration and into 
the target artery extremely challenging, with long fluoroscopic times as a result. In 
cases of marked aortic neck angulation, that necessitate the use of an extra stiff wire 
in the renal artery for sheath placement, renal perforation on sheath advancement has 
also been reported [Kristmundsson T et al, 2009]. Experienced operators have 
developed alternative techniques for dealing with such issues. For example, it may be 
easier to exit the fenestration and advance a wire up the aorta on the outer surface of 
the stent-graft, before turning back down the aorta to the orifice of the renal artery 
using a re-curved catheter. Alternatively, a catheter over a guidewire positioned 
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between the graft and the aneurysm sac can be used to gain retrograde access into the 
renal artery. From a left brachial access the guidewire is then snared and used to allow 
bridging stent deployment between the branch and the target vessel, thus completing 
the procedure [D'Elia P et al, 2010].  
 
Despite recent advances in devices for catheter-based peripheral arterial 
revascularization procedures, the inadequacy of conventional catheters for the 
variable and often unpredictable anatomy of patients with complex arterial disease 
implies that alternative catheter designs are essential. The robotic catheter system is 
effectively a steerable sheath supporting a more flexible inner guide. Consequently, 
the catheter resists the tendency to herniate back into the aorta as wires and other 
endovascular tools are being advanced through its lumen. In the 216 stiff guidewire 
exchanges studied, robotic endovascular catheters maintained stability at target sites 
with zero deflection during stiff guidewire exchanges, independent of the distance the 
catheter was introduced into the target vessel and no loss of access. In contrast, 
conventional catheters required positioning at least 2cm into the target vessel in order 
to avoid catheter deflection and subsequent loss of access. Robotic catheters, 
demonstrated increased stability at point C, the target vessel ostium that may prove 
useful when tackling angulated aortic arches, aneurysm necks and tortuous branches. 
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5.5. Conclusions 
 
As endovascular therapy is becoming more ambitious, there remains a need to 
develop new catheter designs that are more reliably suitable to complex peripheral 
arterial anatomy. Our results demonstrate that robotic endovascular catheters provide 
increased stability at target sites during stiff guidewire exchanges – a vital step for 
securing target vessel access in complex endovascular procedures involving the 
carotid and renal arteries. This enhanced positional control may offer a stable 
platform for future advanced applications involving device delivery or target 
intervention, such as in-situ fenestration, coil embolization and other therapeutic 
catheter-based interventions.  
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Chapter 6. 
Iliac tortuosity: its effect on target vessel 
cannulation in the visceral segment  
 
6.1?Background 
 
The presence of hostile iliac anatomy is a challenge to successful endovascular 
intervention in the aorta and its branches. Adequate ilio-femoral access, endograft 
delivery and successful branch cannulation and stenting are all influenced by aortic 
and iliac tortuosity. Although not an absolute contraindication for standard 
endovascular aneurysm repair, unfavorable iliac anatomy can pose significant 
difficulties with endograft fixation and orientation, and may render some patients 
unsuitable for endovascular intervention [Wolf YG et al, 2001; Rodd CD et al, 2011]. 
It carries a 15-20% complication rate including hemorrhage, rupture, and dissection, 
which may necessitate conversion to open repair [Cuypers PW et al, 2000; Yano OJ et 
al, 2001; Millon A et al, 2009]. It has also been implicated as a cause of late 
complications and endograft failure through progressive distortion, limb retraction or 
occlusion, asymptomatic arterial dissection and endoleak formation [Tillich M et al, 
2001; Hobo R et al, 2007; Hobo R et al, 2008; Millon A et al, 2009]. Severe iliac 
tortuosity can also be responsible for alterations in stent graft configuration before 
and after deployment, as demonstrated in a number of post-marketing trials for 
different manufacturers [Umscheid T et al, 1999; Makaroun MS et al, 2005; Moise 
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MA et al, 2006; Matsumura JS et al, 2008; Fairman RM et al, 2008]. Aortoiliac 
tortuosity is therefore an important factor in the selection, planning, conduct, and 
outcome of endovascular aortic intervention.  
 
In complex endovascular procedures such as fenestrated and branched endografting, 
unfavourable iliac anatomy can impact not only on endograft delivery leading to 
misalignment between the fenestrations/branches and the target vessel ostia but also 
on the performance of the conventional endovascular catheters used for selective 
catheterization as an independent variable  [Haulon S et al, 2007; Bicknell CD et al, 
2009; Haulon S et al, 2010; Amiot S et al, 2010; Greenberg R et al, 2010]. Both these 
factors may subsequently compromise successful and safe target vessel cannulation. 
This study is the first report to date, attempting to quantify the effect of varying 
degrees of iliac tortuosity on the maneuverability and torquability of endovascular 
catheters during target vessel cannulation in the visceral segment in fenestrated 
endografting, comparing conventional and robotic techniques. 
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6.2?Methodology 
 
Aortic Model 
 
The pulsatile silicone CT-reconstructed anthropomorphic phantom (Elastrat Sàrl, 
Geneva, Switzerland) with the in-situ fenestrated stent graft described in Chapter 3 
was used. 
 
Tortuosity Index 
 
To assess the effect of varying degrees of iliac tortuosity on the performance of 
conventional versus robotic endovascular cannulation of the renal arteries, three 
access vessels on the pulsatile phantom were chosen: the right external iliac artery (R 
EIA), the left external iliac artery (L EIA) and the left internal iliac artery (L IIA). 
The LIIA is of course not used as an access vessel in the clinical setting; it was chosen 
for the purposes of this study to reflect the different degrees of tortuosity. For each 
access vessel, the central luminal distance (L1) from the aortic bifurcation to the 
common femoral artery and the straight-line distance (L2) from the aortic bifurcation 
to the common femoral artery measured in a plane perpendicular to the central lumen 
line were calculated from volume-rendered CT reconstructions of the phantom. The 
L1/L2 ratio was used to calculate the iliac tortuosity index (τ) (Fig 6.2.1). 
 
iliac tortuosity index (τ) =  L1 / L2 
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Fig 6.2.1 Calculation of the iliac tortuosity index 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
For each access vessel within the phantom, the central luminal distance (L1) from the aortic bifurcation to the 
common femoral artery and the straight-line distance (L2) from the aortic bifurcation to the common femoral 
artery measured in a plane perpendicular to the central lumen line were calculated from volume-rendered CT 
reconstructions of the phantom. The L1/L2 ratio was used to calculate the iliac tortuosity index, as shown here for 
the REIA.  
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The iliac tortuosity index (τ) was scored as follows specified in consensus reporting 
criteria and used in other publications [Chaikof EL et al, 2002; Karthikesalingam A et 
al, 2010; Rodd CD et al, 2011]; the corresponding values for the iliac angle (ϕ) are 
also shown: 
 
0 Absent  τ ≤ 1.25  160° < ϕ < 180° 
1  Mild  1.25 < τ ≤ 1.5   121° < ϕ < 159° 
2  Moderate 1.5 < τ ≤ 1.6    90° < ϕ < 120° 
3  Severe  τ ≥ 1.6           ϕ < 90° 
 
The access vessel measurements are summarized in the following table (Table 6.2.1): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tortuosity Index (τ) 
 
Severity Score 
 
R EIA 
 
1.36 
 
1  = Mild 
 
L EIA 
 
1.56 
 
      2 = Moderate 
 
L IIA 
 
2.47 
 
 3 = Severe 
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Study protocol 
 
Ten experienced operators (five vascular surgeons, five interventional radiologists) 
were recruited to participate in the study. Each operator was asked to cannulate the 
renal arteries within the phantom using the R EIA, L EIA or the L IIA as the access 
vessel, under fluoroscopic guidance, using conventional and robotic (Hansen Sensei) 
techniques in a randomized order. For conventional procedures, a range of ten 4F to 
5F selective catheters and appropriate endovascular guidewires commonly used for 
renal artery cannulation were available to all operators. Passive intra-procedural 
support was provided by an assistant and a radiographer and C-arm orientation was 
adjusted accordingly, as requested by the operator. Operators were blinded as to the 
access vessel used and its corresponding tortuosity index. All procedures were 
performed in the angiography suite and recorded for blinded video assessment of 
quantitative and qualitative metrics. 
 
DATA COLLECTION 
 
Quantitative metrics 
 
Cannulation times: Renal artery cannulation times from the point the catheter entered 
the aortic bifurcation was measured in minutes using a stopwatch. Vessel cannulation 
was considered satisfactory when the catheter followed the wire at least 3 cm into the 
target vessel. 
 
Movements: The absolute number of translational (linear displacement along a 
trajectory path) and rotational (circular displacement around a centre axis) movements 
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at the wire/catheter tip was counted in a binary fashion by two independent observers 
using blinded-video recordings displaying 2-dimensional fluoroscopic data. 
 
Qualitative metrics 
 
Operator performance: Performance evaluation was carried out using the Imperial 
College Complex Cannulation Scoring Tool (IC3ST) described in previous chapters 
(Chapters 3 and 4). Performance scoring was evaluated by two blinded assessors (C.R 
and C.B), experienced in the use of rating scales. 
 
 
Statistical analysis 
 
The Statistical Package for the Social Sciences version 18.0 (SPSS, Chicago, Ill., 
USA) was used for data analysis. The absence of a normal distribution of the data 
necessitated the use of non-parametric tests for significance. Differences between 
conventional and robotic cannulation were compared using the Wilcoxon signed-rank 
test for related samples. A p value of less than 0.05 was considered statistically 
significant. Inter-observer reliability for the blinded assessors was calculated with the 
Cronbach's alpha test statistic. 
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6.3?Results 
 
6.3.1 Quantitative 
 
In total, 120 cannulations were observed. With increasing iliac tortuosity, time and 
catheter movements for renal artery cannulation using conventional techniques 
increased in a step-wise fashion: median times 7.6min IQR (4.6-9.3) versus 
6.9min(4.2-11.4) versus 17.7min(13.3-22.6) and movements 184(110-351) versus 
251(207-395) versus 569(409-616) for mild, moderate and severe tortuosity 
respectively; p=0.001 between low and high iliac tortuosity severity scores for time 
and movements. Renal cannulation times and movements were significantly reduced 
using the robotic system irrespective of iliac tortuosity severity scores: median times 
1.4min(1.1-1.9) versus 3(2.3-3.3) versus 2.8(1.5-3.9) and movements 19(14-27) 
versus 46(43-58) versus 45(40-66).  The greatest differences between conventional 
and robotic techniques were observed in cases of severe iliac tortuosity (severity score 
≥3) for time: 17.7min IQR (13.3-22.6) versus 2.8min (1.5-3.9); p=0.005 and 
movements: 569 (409-616) versus 45 (40-66); p=0.005 (Fig 6.3.1, 6.3.2). Inter-
observer reliability for measuring the number of movements was calculated with a 
Cronbach’s α of 0.94, indicating a high level of agreement. 
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Fig 6.3.1   
Renal artery cannulation times and iliac tortuosity severity   
 
Bar chart representing renal artery cannulation times with increasing iliac toruosity severity, using conventional 
and robotic techniques (Wilcoxon signed rank test).  
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Fig 6.3.2   
Catheter tip movements and iliac tortuosity severity   
 
Bar chart representing the number of catheter tip movements for renal artery cannulation with increasing iliac 
toruosity severity, using conventional and robotic techniques (Wilcoxon signed rank test).  
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6.3.2 Qualitative  
 
Overall operator performance scores improved significantly using the robotic system, 
irrespective of iliac tortuosity severity. Median IC3ST scores were: 24/35 (19 – 28) 
versus 30/35 (29 – 31), 27/35 (22 – 30) versus 31/35 (30 – 33) and 21/35 (15 – 22) 
versus 33/35 (30 – 35) for mild, moderate and severe iliac tortuosity respectively (Fig 
6.3.3). Reliability between assessors was calculated using Cronbach’s α was 0.85, 
indicating a high level of agreement.  
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Fig 6.3.3   
Operator performance IC3ST and iliac tortuosity severity   
 
 
Bar chart representing operator performance scores on the IC3ST scale for renal artery cannulation with increasing 
iliac toruosity severity, using conventional and robotic techniques (Wilcoxon signed rank test).  
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6.4?Discussion  
 
 
Despite continuing device and technical evolution, remote arterial access remains a 
significant challenge if access vessels are tortuous. Iliac artery tortuosity increases 
with age, is prevalent in aneurysmal disease and can be a limiting factor in 
endovascular intervention, directly impacting on the safe introduction of endovascular 
tools in the aorta and its branches [Wolf YG et al, 2001; Tillich M et al, 2001; Rodd 
CD et al, 2011]. This chapter examines the true effect of tortuosity in a pulsatile 
model and demonstrates the advantages of robotic catheters in this setting. Although 
this study has chosen to assess access vessel tortuosity in a fenestrated model, the 
effects of significant curvature in the iliac segment may be equally applicable to the 
majority of procedures performed through a femoral approach involving selective 
cannulation of target vessels. For fenestrated and branched endografting unfavorable 
iliac anatomy is particularly pertinent. One of the main challenges in these procedures 
is cannulation of the fenestration and visceral orifice via the introduction of guiding 
catheters and stents. With increasing iliac tortuosity as shown in our study, target 
vessel cannulation with conventional endovascular catheters becomes more 
technically demanding. Angulation at the access end of the path trajectory directly 
impacts on manipulation at the distal end of the wire/catheter interface, with limited 
torquability and buckling of the selective catheter, resulting in multiple cannulation 
attempts with frequent catheter changes. Even when the target vessel was successfully 
cannulated with a wire, advancing the less trackable catheters over hydrophilic 
guidewires proved to be difficult for a toruosity severity score of 2 or above, and as a 
result, the catheter/wire often deviated upwards towards the thoracic aorta.  These 
technological deficiencies in the presence of challenging iliac configurations 
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accounted for the observed increased length of time taken, number of movements to 
cannulate vessels; and suboptimal performance of the operators.  
 
Many operators chose to exit the fenestration of the partially deployed endograft and 
advance the wire proximally in the aorta on the outer surface of the device, before 
turning back down to the orifice of the target vessel using a re-curved catheter; a 
technique for visceral artery cannulation used by some. As shown in our study, this 
maneuver may be sufficient for small to moderate degrees of iliac tortuosity, however 
in cases with a high tortuosity index control at the catheter tip is suboptimal and often 
the fabric lip of the fenestration or the stentgraft itself engaging the catheter results in 
repeated catheter manipulations and prolonged cannulation times [Moore R et al, 
2007]. In this study overall, operators using the robotic catheter to cannulate vessels 
were faster, used less movements and with improved performance. This improvement 
in the studied metrics was not affected by changes in iliac tortuosity. Moreover, in 
contrast to the patterns seen with conventional catheters, functionality of the robotic 
catheter was unaffected by iliac tortuosity severity, with faster cannulation times, 
increased positional accuracy and control in terms of catheter tip movements and 
overall operator performance scores, that was particularly evident in the more 
tortuous cases. 
 
Some of these issues are clearly device-specific. Access is primarily related to the 
flexibility, torquability, diameter, shape and stability of endovascular devices. 
Because of the unpredictable anatomy among patients undergoing catheter-based 
peripheral revascularization procedures, including excessive vessel tortuosity and 
extreme angulation at bifurcations, adequate guide catheter positioning and support 
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remain one of the leading challenges. It is often necessary to use catheters with 
complex distal shapes to successfully cannulate the branch vessels. These complex 
catheter shapes can act as a barrier to distal navigation at the target vessel ostia, and 
stability is frequently a problem. The use of larger catheters increases the stability; 
however, flexibility is often compromised.  The robotic catheter acts as kink-resistant 
sheath providing support in key target regions despite severe degrees of iliac 
tortuosity. Enhanced control at the tip of the inner guide reduces the manual skill 
required for individual target vessel cannulations which are achieved faster, with 
fewer movements and increased positional precision protecting therefore the aorta and 
its branches from potentially embologenic and traumatic manipulations. One may 
argue that the differences between conventional and robotic techniques observed in 
our study may not be as clinically relevant for small degrees of iliac tortuosity, 
however, in cases with a high tortuosity index where catheter manipulation and 
control really becomes an issue, a more advanced catheter tool may indeed improve 
safety and efficacy.  
 
Although not directly studied here, branch vessel stenting following successful 
cannulation of the target branch should also be taken into consideration. Even if a 
branch vessel with an acute downwardly oriented takeoff can be selectively engaged 
via the femoral approach, subsequent branch stent advancement still may not be 
possible. The presence of severe aorto-iliac tortuosity or occlusive disease may 
mandate approaching the vessel from an upper extremity approach, which in itself 
carries a significant embolic risk [Kessel DO et al, 2003]. The use of a catheter-
guiding sheath is another alternative to allow tracking of extra-stiff wires and aid in 
overall stability [Rahimi SA et al, 2010]. The sheath is advanced until it is close to the 
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target vessel ostium, and with its support an angled glide catheter and glide wire 
combination can be used to cannulate the vessel [Moore R et al, 2007]; even with this 
approach however, perforation of the target vessel on sheath advancement has been 
reported [Kristmundsson T et al, 2009]. In contrast, as shown in the previous chapter 
(Chapter 5), the robotic device offers increased stability during stiff guidewire 
exchanges during target vessel cannulation both in the aortic arch and the visceral 
segment.  
 
Various adjuncts may be utilized to assist with tortuous iliac anatomy. The most 
commonly used technique involves utilization of a longer sheath to support the 
catheter in the less tortuous aortic segment. Buddy wires, through and through wires 
from femoral to brachial access sites (the so- called "dental floss" technique) [D'Elia P 
et al, 2010], balloon angioplasty and stenting can all be attempted. These maneuvers 
can be useful for many non-calcified tortuous iliac vessels, however, when heavy 
calcification [Bowman JN et al, 2010] is present, vessel dissection and rupture are 
potential risks, and embologenic sequelae may also occur when the brachial approach 
is used. Iliac conduits are used in 9.4 – 22% [Matsumura JS et al, 2008; Fairman RM 
et al, 2008] of anatomically challenging cases where iliac size is the main limiting 
factor. This technique requires a retroperitoneal incision and dissection, followed by 
placement of a 10 mm Dacron graft onto the common iliac bifurcation anastomosed in 
an end-to-side fashion. In our unit, we often tunnel the graft to the femoral region to 
avoid device entry into the native vessel at a steep angle. Although performed most 
often for introduction of stent grafts, this maneuver does reduce a number of curves in 
the ilio-femoral segment and in severely tortuous disease in patients that have 
multiple fenestrations to cannulate this technique may be useful. Upon completion of 
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the procedure, the graft can be transected and oversewn, leaving a small cuff of 
prosthetic on the iliac vessel, or it can be anastomosed to the common femoral artery 
forming an iliofemoral bypass. This technique has its advantages if there is a high 
likelihood of re-intervention. The morbidity of this approach, however, cannot be 
underestimated. The use of conduits via a retroperitoneal approach is associated with 
increased blood loss, operative time (by 82%) and median hospital length of stay as 
well as postoperative complications (up to 21%) [Lee WA et al, 2003; Fairman RM et 
al, 2008]. More recently, “internal endoconduit” techniques have been described, 
involving deployment of an iliac stent followed by angioplasty and controlled rupture 
of the iliac artery, to allow passage of the endograft delivery device; reports however 
are scarce and experience limited [Wu T et al, 2010; Peterson BG 2010]. 
 
Specifically for fenestrated stent grafting the problem may be compounded by graft 
related issues. Rotation of the custom-made endograft and subsequent misalignment 
between the fenestrations/branches and the target vessel ostia can lead to increased 
difficulty with target cannulation. In order to overcome some of the limitations of 
standard catheter technology and simplify the target vessel cannulation process, newer 
devices incorporating preloaded wires, catheters and sheaths have been developed. 
Preliminary results have shown that cannulation times are considerably shorter and 
access into the target vessel easier than with standard fenestrated or branched systems. 
Despite these important developments in stent graft design, however, it has become 
apparent that severe tortuosity of the iliac vessels can cause rotation of the device and 
twisting of the preloaded wires/catheters or sheaths which can lead to trauma and 
vessel loss [Manning BJ et al, 2010]. 
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6.5?Conclusions 
 
Despite recent advances in devices and techniques for catheter-based peripheral 
arterial revascularization procedures, there remains a need for the design of guide 
catheters capable of providing adequate support and maneuverability in patients with 
challenging anatomy. Although contemporary catheters may be sufficient for many 
revascularization procedures, the inadequacy of these tools for the variable and often 
unpredictable anatomy of patients with peripheral arterial disease implies that 
alternative catheter designs are essential.  
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Chapter 7. 
Skill acquisition and learning curves for 
endovascular robotics 
 
7.1?Background 
 
Minimally invasive intervention coupled with the introduction of new technology 
creates new challenges in terms of clinical outcomes as well as training and 
credentialing. As seen in laparoscopic surgery, learning curves are steep [Lin JC et al, 
2011; Ali MR et al, 2010; Staudacher C et al, 2010; Bagdasarian RW et al 2000]. The 
rate of skill acquisition often varies between surgeons and is influenced by patient 
selection and operative complexity, requiring therefore appropriate case-mix 
adjustment [Kayano H et al, 2011; Tekkis PP et al, 2005; Schauer P et al, 2003; 
Reissman P et al, 1996]. The steep learning curves are attributed to many aspects of 
current technologies utilized and mostly relate to the 2D imaging and instrument 
limitations as well as ergonomics [Bittner JG et al, 2008; Jordan JA et al, 2000]. 
Robotic assistance in laparoscopic surgery using the Da Vinci system allows for 
stereoscopic vision and improves dexterity, resulting in faster and more accurate 
performance of laparoscopic tasks; in terms of learning curves however, skill 
acquisition favors conventional laparoscopy with a flat-learning curve in experienced 
operators, suggesting that robotic assistance might be most beneficial in 
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inexperienced subjects [Novotný T et al, 2011; Heemskerk J et al 2007].  
 
In endovascular therapy, as seen with other fields of minimally invasive surgery, the 
level of procedural difficulty has increased in recent years, as its applicability extends 
to a more complex patient cohort. Catheter-based intervention requires a high degree 
of skill while manipulating intravascular devices often using counterintuitive hand 
movements. As case complexity increases and endovascular intervention becomes 
more ambitious, the mastering of endovascular skills can be challenging. This is 
highlighted by the extensive caseload, and the long mentoring and proctoring process 
required in order meet credentialing guidelines for endovascular procedures [White 
RA et al, 1999; Ahmadi R et al, 2001; Verzini F et al 2006].  
 
The data presented in previous chapters suggests that robotic endovascular catheter 
technology has the potential to reduce the manual skill required for complex tasks. 
The impact of this technology however, on the skill acquisition for endovascular 
procedures has not been explored. This study aims to investigate the learning curve 
pattern in novice subjects for robotic endovascular catheters versus conventional 
techniques. 
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7.2?Methodology 
 
Aortic Model 
 
The pulsatile silicone CT-reconstructed anthropomorphic phantom (Elastrat Sàrl, 
Geneva, Switzerland) representing a Type I aortic arch with bovine configuration of 
the left CCA described in Chapter 4 was used. 
 
Study protocol 
 
Ten novice subjects (medical students) with no prior endovascular training were 
recruited and consented to participate in the study. All participants were given an 
information sheet followed by a standardized didactic teaching session that included 
endovascular techniques, apparatus being used, study purpose and assessment 
metrics. The subject’s understanding of this introductory course was then assessed 
using a questionnaire. Feedback was provided before progressing to the next stage. 
Prior to commencing the study, a short, practical demonstration of target vessel 
cannulation and equipment use was also provided. Participants were then allowed to 
practice cannulating the left subclavian artery (LSA) in the pulsatile aortic arch 
phantom.  
 
Subjects were randomly assigned to conventional and robotic techniques as the first 
procedure undertaken, and were asked to sequentially cannulate four arch vessels 
namely the LSA, left common carotid artery (LCCA), right common carotid artery 
(RCCA) and right subclavian artery (RSA) via the femoral approach. A range of 4F to 
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5F selective catheters and appropriate endovascular guidewires, commonly used in 
arch vessel cannulation procedures, were available to all operators. The Hansen 
SenseiTM System (Hansen Medical, Mountain View, CA, USA) was used for all 
robotic cannulations. 
 
All procedures took place in the Simulated Endovascular Suite (Fig 7.2.1 and 7.2.2) 
and were recorded for video assessment. Each task was repeated weekly over a 5-
week period (10 sessions per subject, 100 procedures in total). At the end of the 5-
week training programme, video recordings were analyzed for quantitative and 
qualitative metrics. Video footage was blinded and randomized, identifiable only by 
an internal coding system. Subjects were also sent a post-training self-report 
questionnaire on their overall experience with conventional and robotic endovascular 
techniques. 
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Fig 7.2.1  Conventional cannulation in the Simulated Endovascular Suite 
 
 
 
 
 
 
 
 
 
The pulsatile aortic arch phantom is covered with surgical drapes, and video output of the real-time image is 
projected onto the LCD monitor screen. 
 
Fig 7.2.2  Robotic cannulation in the Simulated Endovascular Suite 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Workstation monitors display real-time images of the pulsatile phantom, and the operator manipulates the robotic 
catheter remotely via the hand-operated 3-dimensional joystick. 
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DATA COLLECTION 
 
Quantitative metrics 
 
Total procedure times and individual target vessel cannulation times were measured 
using a stopwatch. Times were recorded from the catheter entering the phantom at a 
fixed point of the descending aorta, and vessel cannulation was deemed satisfactory 
when the catheter was seen in a stable position over the guide wire and at least 3 cm 
into the target vessel. In addition, the absolute number of rotational and translational 
movements at the wire/catheter tip as well as wall hits during cannulation attempts 
were recorded in a binary fashion by two observers (P.C, P.N), who were blinded to 
individual operators and corresponding session.  
 
Qualitative metrics 
 
Performance evaluation was carried out using the Imperial College Complex 
Cannulation Scoring Tool (IC3ST) described in previous chapters. Performance 
scoring was analysed by two blinded assessors (C.R and F.C), experienced in the use 
of rating scales. 
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Statistical analysis 
 
Data were analyzed with the Statistical Package for the Social Sciences version 18.0 
(SPSS, Chicago, IL, USA). Learning curves were assessed using a Friedman (non-
parametric repeated-measures analysis of variance) test. Sequential comparisons were 
made to identify plateau levels for all significant variables. The Wilcoxon signed rank 
test was used to determine both skill improvement from the first to fifth session and 
differences between conventional and robotic techniques. All tests were two-tailed 
and considered significant for p < 0.05. Inter-observer reliability for blinded assessors 
was evaluated using the Cronbach’s alpha coefficient (0.7-0.8 is considered to be 
significant, >0.09 for a high-stakes assessment).  
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7.3?Results  
 
Skill acquisition 
 
All study participants completed the 5-week training programme. Good interobserver 
reliability for blinded assessors was achieved for all metrics: total number of 
movements (Cronbach’s alpha = 0.99), wall hits (0.75) and IC3ST scores (0.87). 
Subjects exhibited statistically significant differences when comparing initial to final 
performance (week 1 versus week 5) for procedure times and catheter-tip movements. 
The 5-week training programme had no effect on wall hits. A flat learning curve was 
observed for robotic cannulation in terms of overall performance scores. 
 
Sequential non-parametric comparisons identified a learning curve plateau level at 
week 3 for total procedure times and IC3ST scores using robotic technology; an 
earlier plateau at week 2 was seen for catheter-tip movements. With conventional 
catheterization, the plateau level was identified at week 3 for total number of 
movements and week 4 for total procedure times; no plateau was reached for total 
number of vessel wall hits and performance scores, which continued to improve 
throughout the training programme. Table 7.3.1 summarizes the results for weeks 1 
and 5 including learning curve plateau levels for the different catheter types. 
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Table 7.3.1 
* 
 
 
 
 
 
 
 
 
 
Comparison between catheter types 
 
Direct comparison between catheter types for median procedure times indicated that 
conventional catheterization was significantly faster for weeks 4 and 5 (Fig 7.3.1). 
Subjects, however, made significantly fewer catheter-tip movements using robotic 
technology every week throughout the programme (Fig 7.3.2). The robotic system 
virtually eliminated contact with the aortic arch proximal to the CCA origin and 
significantly reduced overall wall hits (Fig 7.3.3). It also resulted in significantly 
higher overall IC3ST performance scores (Fig 7.3.4). 
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Fig 7.3.1 Procedure times over the 5-week training programme 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bar chart representing median procedure times (min) with conventional versus robotic techniques over the 5-week 
training programme (Wilcoxon signed rank test). The learning curve pattern in the lower panes, for each individual 
operator is also shown. 
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Fig 7.3.2 Catheter movements over the 5-week training programme 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bar chart representing median number of catheter-tip movements with conventional versus robotic techniques over 
the 5-week training programme (Wilcoxon signed rank test). The learning curve pattern in the lower panes, for 
each individual operator is also shown. 
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Fig 7.3.3 Vessel wall hits over the 5-week training programme  
 
 
 
 
 
 
 
 
Bar chart representing median number of vessel wall hits at the aortic arch proximal to the CCA and at the carotid 
vessel ostia with conventional versus robotic techniques, over the 5-week training programme (Wilcoxon signed 
rank test).  
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Fig 7.3.4 Overall performance scores during the 5-week training programme  
 
  
Graph representation of the overall IC3ST performance with conventional versus robotic cannulation techniques 
during the 5-week training programme.  
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Self-report questionnaires 
 
Eight out of 10 study participants scored the robotic system at 3 on a 3-point scale, 
indicating that the system was easy to learn on and steer, and was intuitive and 
responsive to operator commands. By contrast, 9/10 operators scored the conventional 
catheters at 2, on the same scale. Overall, participants preferred the robotic system 
and felt that it significantly enhanced their performance as a whole. The self-report 
questionnaire is shown below (Fig 7.3.5): 
 
Fig 7.3.5 Participant Questionnaire  
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7.4?Discussion 
 
The widespread adoption of endovascular therapy has important implications on the 
training and credentialing guidelines for vascular specialists. Advanced endovascular 
procedures are unique in that the risk posed to the patient as a result of the operator’s 
learning curve is significant and immediately apparent. Consequently, trainees are 
challenged by the prolonged learning curves associated with mastering complex 
techniques and the acquisition of essential generic skills [Gould D, 2010]. Although 
the apprenticeship model has stood the test of time, simulators dedicated to 
endovascular training are now available to offer trainees the opportunity to acquire 
basic skills and to undertake complex tasks outside the operating theatre with a view 
to allow for the early parts of the operators learning curve to take place within a safe 
environment [Ahmed K et al, 2010; Neequaye SK et al, 2007]. They do not however, 
reduce the operation requirements or the learning curve [Aggarwal R et al, 2006]. A 
further obstacle faced by the endovascular specialist trainee involves the limitations of 
current endovascular catheter technology. Any technological advancement that 
reduces the learning curve will have a significant impact on the length of 
endovascular training and importantly patient safety. There is a pressing need 
therefore, to improve endovascular catheter technology in order to shorten the 
learning curve and in turn improve patient outcomes. 
 
A variety of advanced endovascular catheters have been developed in an attempt to 
reduce the technical burden to the endovascular specialist and have been widely 
adopted in transvenous cardiac mapping and ablation procedures [Arya A et al, 2010; 
Matsuo S et al, 2010; Saliba W et al, 2008; Kanagaratnam P et al, 2008]. The early 
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learning curve seen in transvenous mapping and ablation procedures using robotic 
technology through longer procedure times, although not formally assessed, is though 
to be mainly due to additional set-up times [Malcolme-Lawes L et al, 2010]. Pre-
clinical testing of robotic endovascular catheters against conventional cannulation 
techniques in the hands of experienced operators has shown promise in enhancing 
target vessel cannulation, reducing instrumentation and improving operator 
performance as demonstrated in previous chapters. This chapter aimed to evaluate the 
learning curve pattern of endovascular robotics in novice subjects. 
 
In this study, quantitative and qualitative metrics improved throughout the 5-week 
training programme (10 sessions for each subject), indicating that novices progressed 
through the learning curve with regards to basic endovascular skills. Evidence of 
improvement in performance is supported by the fact that subjects showed less 
variability in metrics during their training, as demonstrated by a reduction in the IQR. 
This is an important parameter to look for when evaluating skill acquisition and 
suggests consistency; the rate of improvement in performance seems to decelerate as 
the learning curve reaches a plateau. 
 
Use of robotic technology resulted in significantly superior overall performance 
scores, with an earlier learning curve plateau. The clear advantages with regard to 
catheter movements and vessel wall hits observed indicate enhanced economy of 
movement and navigational accuracy. Although catheter-tip movements and vessel 
wall hits are surrogate measures for embolic risk, wall hits at the arch proximally to 
the CCA origin were virtually eliminated by the robotic system. This is likely to result 
from the greater range of motion that can be achieved with the RC and the increased 
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3D control at the catheter tip. Overall IC3ST performance scores were significantly 
improved using the robotic system over the 5-week period. During a total of 50 
robotic cannulation procedures, 48 procedures scored between 21/35 and 34/35, 
indicating a competent performance and 2 procedures achieved a score of 35/35, 
indicating an excellent performance. Although a significant improvement over the 5-
week study period was observed for the overall IC3ST performance scores with 
conventional cannulation techniques, 20 procedures achieved a score between 7/35 
and 20/35 and 30 procedures scored between 21/35 and 34/35, with no operators 
achieving an excellent procedure score of 35. This illustrates the intuitive nature of 
the robotic technology as the majority of operators demonstrated a performance of a 
high standard at an earlier stage. 
 
Although not directly quantified in this study, we observed that with experience, 
participants demonstrated a cognitive improvement in performance by developing 
different cannulation strategies using the robot and were able to keep the catheter low 
in the arch whilst directing the wire into the vessel by manipulating and steering its 
tip. By contrast, with conventional catheters, it was necessary to advance the catheter 
in closer proximity to the vessel ostium before guiding the wire through its lumen. 
Subcategory analysis of the IC3ST scores, revealed that participants demonstrated 
increased awareness of areas of significant embolic risk using the robotic catheter at 
week 2, most likely secondary to enhanced catheter control.  
 
Surprisingly, subjects took significantly longer in cannulating all four arch vessels 
with robotic catheters. Novice subjects, however, often assume that faster completion 
of a technical task represents competence. Speed of task completion has been used 
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previously to assess competency during surgical procedures; a fast but unskilled 
operator, however, is less desirable than a slow, skilled operator. Faster completion of 
a procedure, therefore, is at best a crude measure of technical skill, and cannulation 
times alone do not reflect overall performance as demonstrated by IC3ST scores and 
all other metrics, especially for robotic cannulation techniques [Van Herzeele I et al, 
2008; Johnson S et al, 2006; Moorthy K et al, 2003]. 
 
Limitations 
 
This study is limited by the use of in vitro phantoms, as these experimental models do 
not reflect all the challenges of catheter navigation in atherosclerotic aortic arches and 
the carotid bifurcation within a clinical setting and even high-fidelity simulators can 
only replicate a subset of actual clinical scenarios. More importantly, catheter 
manipulation represents a specific but challenging part of many endovascular 
procedures; there are numerous factors contributing to the long learning curve of the 
endovascular specialist and they span technical skills as well as non-technical skills, 
such as patient selection, anatomical awareness and teamwork that have not been 
directly studied here. Nonetheless, robotic technology is perhaps the ideal platform 
whereby the integration of simulators for teaching purposes can occur. Our results are 
also reliant on the level of the subject’s motivation for performing well in a simulated 
environment with no perceived risk of adverse outcome, and therefore, may have 
been influenced by the individual subject’s attitude and aptitude for new skill 
acquisition. 
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7.5?Conclusions  
 
Using this experimental model, novice subjects acquired rudimentary endovascular 
skills in a 5-week training programme utilizing both conventional and more advanced 
robotic endovascular catheter technologies. Robotic catheter techniques, although 
more intricate, do not seem to take longer to master and offer clear advantages with 
regard to positional control, at a faster rate. Robotic technology seems to be the 
intuitive and advanced skill acquisition occurs with minimal training. It may, 
therefore, have a significantly shorter path to proficiency allowing an increased 
number of trainees to attempt more complex endovascular procedures earlier and with 
a greater degree of safety. 
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Chapter 8. 
Advanced applications:  
In-situ Fenestration 
 
8.1?Background 
 
Diseases of the aorta involving arch and visceral branch vessels require challenging 
therapeutic maneuvers to ensure preservation of arterial flow within vital branches. 
Bespoke fenestrated and branch stent graft technology has shown encouraging short- 
and mid-term results in selected patients. Despite tremendous technological advances 
in this field however, factors such as the inherent delay in device manufacturing, 
anatomical and technical challenges, high degree of planning, and cost limit the 
uptake of this technology and render it unsuitable for urgent and emergency cases. In 
situ fenestration of aortic stent grafts is an attractive alternative that eliminates the 
need for preoperative custom tailoring with the potential to widen the therapeutic 
options available and to offer a bailout option after inadvertent side branch occlusion.  
 
The concept of in situ fenestration involves intentionally covering aortic branches 
with an endograft and then reestablishing blood flow by fenestrating the fabric in 
vivo. Once the fabric has been breached, the fabric hole can then be dilated to a 
desired diameter and a branch stent is placed to maintain perfusion of the target 
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vessel. This technique can be performed in either a retrograde (from within the lumen 
of the side branch, therefore requiring downstream access) or an antegrade (from 
within the lumen of the stent graft) fashion and may be potentially applied to all major 
aortic side branches. 
 
Arch Vessels 
 
McWilliams et al first described retrograde in situ fenestration in bench and animal 
models [McWilliams RG et al, 2003], followed by the first successful clinical 
application in the left subclavian artery (LSA) via supraclavicular access using the 
back end of a 0.018-inch guidewire, a needle and serial cutting balloons in a modified 
Zenith thoracic endograft [McWilliams RG et al, 2004]. A similar approach was used 
to repair an aortic arch aneurysm by fenestrating the LSA with acute angulation of the 
vessel in relation to the arch, using through and through wire access, a precurved 
semirigid sheath and serial balloon dilatations [Manning BJ et al, 2010]. Retrograde 
fenestration via surgical isolation of the left common carotid artery by puncture and 
balloon dilatation of a thoracic endograft for endovascular exclusion of a descending 
thoracic aortic aneurysm, has also been reported [Eid-Lidt G et al, 2008].  
 
The feasibility of complete aortic arch reconstruction using the retrograde approach 
and conduit implantation with cerebral circulatory support was first demonstrated in 
cadaveric and animal models; balloon-anchored needle dilators and radio frequency 
(RF) plasma electrode catheters followed by balloon dilatations were used to create 
fenestrations [Numan F et al, 2008]. Sonesson et al applied this concept in the 
emergency clinical setting to treat an acute aortic arch rupture; cerebral flow was 
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maintained using a temporary bypass from the left femoral artery to both carotids 
perfusing both the anterior and posterior cerebral circulation [Sonesson B et al, 2009]. 
Successful laser (Turbo Elite laser ablation catheter, Spectranetics, Colorado Springs, 
CO) in situ fenestration of a Talent thoracic endograft via percutaneous access was 
recently used to revascularize the LSA in a patient with acute traumatic aortic 
transection [Murphy EH et al, 2009].  
 
Visceral and Renal Vessels 
 
Retrograde in situ fenestration is difficult to apply to the abdominal aorta because of 
the lack of downstream branch artery access. Inadvertent coverage of target vessels 
below the diaphragm traditionally mandates conversion to laparotomy largely because 
of limitations in current device technology and imaging modalities. Percutaneous 
access to the visceral and renal vessels can be challenging without laparoscopic 
placements of sheaths, coil embolization, or endoscopic closure of the arterial 
puncture on completion. More recently the “chimney” technique has been proposed, 
which involves deployment of a covered or bare-metal stent outside and parallel to the 
aortic endograft, thereby creating a conduit for branch revascularization [Donas KP et 
al, 2011]; its long-term effectiveness and durability however is yet to be proven. Tse 
et al described antegrade fenestration of abdominal aortic stent grafts in canine 
models under fluoroscopic guidance using intravascular ultrasound (IVUS, Volcano 
Corporation, Rancho Cordova, CA) as an adjunct; renal artery stents were inserted 
bilaterally prior to fenestration and used as fluoroscopic landmarks [Tse LW et al, 
2007]. The same group recently published a similar experiment in canine models, 
using RF probes for endograft perforation having marked the renal arteries bilaterally 
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with detachable coils [Tse LW et al, 2010]. 
 
Although the technical feasibility of retrograde in situ fenestration techniques in the 
arch has been established, clinical reports are scarce and its applicability to the 
visceral segment is limited. The antegrade approach, remains at the experimental 
phase and the optimum method for fashioning the fenestrations is yet to be 
determined. This chapter aims to examine different methods of graft puncture and 
dilatation and assess the feasibility of robot-assisted antegrade in situ fenestration in 
vivo. 
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8.2?Methodology 
 
8.2.1 Preliminary phase  
 
Fashioning of the fenestrations 
 
Current endografts are not specifically designed for the purpose of fabric perforation 
and fashioning fenestrations. Modified needles are mostly used to create the 
fenestration, which is then dilated with either a cutting balloon or ordinary 
percutaneous transluminal angioplasty balloons. Tear propagation is greatly affected 
by changes in yarn and fabric geometry [Primentas A, 2001] and therefore different 
fabrics react differently to perforation and subsequent dilatation. Tearing occurs due 
to breakage of fabric cross-yarns as a result of lateral applied tension; in fabrics with 
low yarn mobility, such as the high-density fabrics used for endovascular grafts, high 
stress concentrations are found to develop at the deformation or tear initiation site 
[Hamkins CP et al, 1980]. Consequently graft fenestration is one of the areas of 
greatest concern as longitudinal propagation of the fabric tear extending beyond the 
ostium of the target vessel may result in significant periostial endoleaks and aneurysm 
rupture.  
 
The purpose of this experimental study was to assess the effect of needle perforation 
and sequential dilatation with either standard or cutting angioplasty balloons on 
various commercially available stent grafts in vitro. The specific aim was to identify 
the optimal fenestration technique via quantitative and qualitative assessment.  
 
 168 
Graft fenestration techniques were tested on three different commercially available 
stent grafts:  
 
• Talent monofilament twill woven polyester (Dacron) (Medtronic Inc., 
Minneapolis, Minnesota, USA); ∼ 0.09 mm thickness. 
• Zenith multifilament tubular woven polyester (Dacron) (Cook Vascular Inc., 
Brisbane, Australia); ∼ 0.15 mm thickness. 
• Endofit thin-walled expanded polytetrafluoroethylene (ePTFE) (LeMaitre 
Vascular Inc., Massachusetts, Burlington, USA).  
 
Fabric punctures were made using a 20-gauge needle and fenestrations were 
sequentially dilated at 30°, 60° and 90° angles using 6mm standard angioplasty 
(Sterling™ Monorail® Balloon, Boston Scientific, Natick, Mass, USA) or 7mm 
cutting balloons (Boston Scientific, Natick, Mass, USA) (Fig 8.2.1). With each 
balloon, the pressure was gradually increased to 10 atm until the balloon was fully 
open with no waist caused by the endograft; 137 fenestrations were fashioned in total. 
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Fig 8.2.1.  Fenestration fashioning in vitro  
 
 
Graft punctures using a 20-gauge needle and subsequent balloon dilatation of the fenestrations in vitro at 30°, 60° 
and 90° angles. 
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Quantitative and qualitative assessment 
 
The fenestrations were evaluated using a Nikon Eclipse E400 microscope with a UV 
light source, Phase Contrast and a Nikon DXM 200 digital camera. Magnifications in 
the range of 2-100X were undertaken and images were captured using the 
microscope’s software. Specimens were examined to determine fenestration size, 
shape and margins specifically assessing the degree of fibre tears, aggregation and 
distortion using a scoring sheet (Table 8.2.1). Qualitative assessment was carried out 
by four blinded observers (C.R, C.B, M.H, N.C).  
 
Statistical analysis 
 
The Statistical Package for the Social Sciences version 18.0 (SPSS, Chicago, Ill., 
USA) was used for data analysis. The non-parametric distribution of the data 
necessitated the use of non-parametric tests for significance. Differences between 
fenestrations were compared using the Kruskal-Wallis test. A p value of p < 0 .05 was 
considered statistically significant. Inter-observer reliability for the blinded assessors 
was calculated with the Cronbach's alpha test statistic. 
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Table 8.2.1. Qualitative scoring of the fenestrations in vitro 
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8.2.2 Experimental phase  
 
The purpose of this experimental study was to assess the feasibility of robot-assisted 
antegrade in situ fenestration of aortic endografts in the visceral segment in vivo. 17 
aortic branches in total were targeted, namely: 16 renal arteries and 1 superior 
mesenteric artery, in 8 large (65-100kg), fully anesthetized and heparinized swines. 
All procedures were performed under fluoroscopic guidance in the angiography suite, 
in compliance with the Institutional Animal Care and Use Committee (IACUC) and 
Animal Welfare Act guidelines in an accredited animal care facility (Hansen Medical, 
Mountain View, CA). 
 
Percutaneous access was gained via the common femoral vessels via 9F and 18F 
sheaths. Rotational angiography to create an arterial roadmap was used in 5/8 animal 
cases. For the remaining 3 cases, the position of the target vessels was marked on the 
fluoroscopy screen in an anteroposterior (AP) projection. Intravascular ultrasound 
(IVUS) technology was used as an adjunct in 2 cases. For each swine, 16-18mm iliac 
extension woven polyester endografts (Medtronic Inc, Minneapolis, Minnesota, USA) 
served as the main body device, and were introduced in the porcine aorta via the 
femoral access route. Under fluoroscopic control, the main aortic stent was positioned 
so that spaces between the metallic struts were located at the target vessel ostia and 
was then fully deployed across the visceral segment covering the target vessels. The 
Hansen SenseiTM System (Hansen Medical, Mountain View, CA, USA) was used for 
all cases and the Artisan robotic catheter was introduced via the common femoral 
artery using an 18F sheath. The virtual catheter on the robotic workstation monitor 
was aligned with the robotic catheter in AP, 40 degrees right anterior oblique and left 
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anterior oblique configurations to improve navigational accuracy. The robotic catheter 
tip was then positioned against the fabric of the main body device, adjacent to the 
ostium of the target vessel. The fabric was punctured with a 20-gauge customized 
flex-tip trans-septal needle (Hansen Medical, Mountain View, CA, USA) that was 
introduced and kept in place by the robotic arm to ensure that the fabric was 
perforated in the center of the ostium of the target vessel under continuous 
fluoroscopic monitoring. The position was confirmed by a small amount of contrast 
injected through the needle. 
 
For each branch vessel targeted, a 0.014-mm guide wire (Cordis Corp., Miami, 
Florida, USA) was threaded through the needle and into the target vessel.  The needle 
was exchanged for serial 4 x 20 mm and 5 x 20 mm angioplasty balloons (Boston 
Scientific, Natick, Mass, USA) over the wire and through the lumen of the robotic 
catheter for serial dilatations of the fenestration fashioned. A 6 x 12 mm balloon 
expandable bare metal stent (Formula 418® Biliary Balloon Expandable Stent, Cook 
Medical Inc., Bloomington, IN, USA) was then introduced via the robotic catheter 
into the target vessel. The robotic catheter was autoretracted and repositioned with 
fine movements to allow for balloon expansion, and the optimum angle was 
subsequently obtained to maintain stability during stent deployment. 
 
Completion angiography was performed for all cases to assess patency of the target 
vessels. All animals were sacrificed according to Animal Welfare Act guidelines. 
Autopsy was performed in all cases the aorta, branch arteries and kidneys were 
harvested. The explanted endograft was subsequently analyzed with regards to the 
degree of fabric tear and seal adequacy.  
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8.3?Results 
 
8.3.1 Preliminary phase  
 
Compared to Dacron, PTFE grafts were easier to puncture and dilate with standard 
angioplasty balloons; Medtronic and Zenith Dacron grafts resisted low-pressure 
dilatation. The fabric of the Zenith stent graft was the most resilient and resulted in 
bursting of the balloon when the pressure exceeded 10 atm. Differences observed in 
the size of the fenestrations fashioned, also reflect the different tensile strengths of the 
fabrics tested. PTFE resulted in significantly larger diameter fenestrations: 5.2mm 
(4.5-6.6) versus 0.9mm (0.5-1.5) and 0.6mm (0.3-1.3) for Medtronic and Cook 
Dacron grafts respectively; p<0.001 (Fig 8.3.1). 
 
In terms of descriptive and qualitative metrics following microscopic evaluation, there 
was good inter-observer reliability between assessors with a Cronbach’s α=0.89. 
PTFE graft puncture and dilatation resulted in elliptical fenestrations, oriented 
transversally along the endograft. Dacron fenestrations were mostly squared, 
however, in the Medtronic grafts, the fenestrations appeared circular when the 
needle/balloon was introduced at a 90° angle (Fig 8.3.2). 
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Fig 8.3.1  Endograft material and fenestration size  
 
 
 
 
 
 
 
 
 
 
 
Bar chart representing mean fenestration dimensions post dilatation with standard angioplasty balloons at 30°, 60° 
and 90° angles. Fenestration resulted in significantly larger diameter defect in PTFE grafts versus Dacron fabrics, 
p<0.001 (Kruskal-Wallis test). 
 
Fig 8.3.2  Endograft material and fenestration shape 
 
 
 
 
 
 
 
 
 
 
Bar chart representing descriptive assessment with regards to fenestration shapes post dilatation with standard 
angioplasty balloons at 30°, 60° and 90° angles.  
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In Medtronic grafts, fenestration quality was significantly higher when the needle was 
introduced at 90° angles with clean, circumferential fibre aggregation (yarn) and 
minimal number of fibres and tears beyond the fenestration margin visible. PTFE 
graft puncture and dilatation also scored highly in terms of fenestration margins with 
smooth edges and no indication of fraying, especially at 90° angles; however a 
significant number of margin tears was observed with increasing balloon pressures. 
Cook grafts exhibited extensive fibre distortion at the fenestration margins and a large 
number tears were observed in 50% of specimens tested (Fig 8.3.3, Fig 8.3.4, Fig 
8.3.5). Cutting balloon use resulted in significantly more fabric tears in all endograft 
types with extensive fibre distortion and fraying and poor overall quality fenestrations 
(Fig 8.3.6). 
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Fig 8.3.3 Endograft material and fenestration margin quality 
 
 
 
 
 
 
 
 
 
 
Bar chart representing qualitative assessment scores for fenestration margins mean post dilatation with standard 
angioplasty balloons at 30°, 60° and 90° angles, where 4 represents the maximum attainable score.  
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Fig 8.3.4 Endograft material and fenestration margin tears  
 
  
Chart representing percentage of fenestration margin tears observed post dilatation with standard angioplasty 
balloons for the three different endograft materials. Corresponding microscopic images (8X and 80X) of the 
fenestration margin tears are also shown. 
 
 179 
Fig 8.3.5 Microscopic appearance of fenestrations in vitro  
 
  
Microscopic images (8X) of the fenestrations in situ observed post dilatation with standard angioplasty balloons 
for the three different endograft materials at 30°, 60° and 90° angles.  
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Fig 8.3.6 Endograft material and fenestration margin tears using a cutting 
balloon 
 
  
Chart representing percentage of fenestration margin tears observed post dilatation using cutting balloons for the 
three different endograft materials. Corresponding microscopic images (8X and 80X) of the fenestration margin 
tears are also shown. 
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8.3.2 Experimental phase  
 
17 aortic branches in total were targeted, namely: 16 renal arteries and 1 superior 
mesenteric artery, in 8 large (65-100kg), fully anesthetized and heparinized swines. 
The results of the preliminary phase of the study indicated that Medtronic Dacron 
endografts responded well to needle puncture and subsequent balloon dilatation 
resulting in circular fenestrations with clean margins, good fibre aggregation and low 
incidence of fabric tears; they were therefore chosen to serve as the main body device 
for the in vivo experiments. The robotic catheter tip was positioned against the fabric 
of the main body device, adjacent to the ostium of the target vessel to facilitate needle 
puncture and serial dilatation at 90° angles, in order to produce high quality 
fenestrations as shown in the in vitro studies described earlier in this chapter. Stent-
graft puncture and target-vessel cannulation with a guidewire was possible in 15/17 
vessels attempted and subsequent branch-stent deployment was successful in 13/15 
vessels. The technique is shown in Fig 8.3.7, 8.3.8 and 8.3.9. In 2 cases, attempts at 
needle puncture were unsuccessful due to insufficient angulation of the customized 
needle and the limited workspace within the small diameter porcine aorta (13 – 
16mm). For the same reason, and despite the added support of the robotic catheter 
sheath, the angioplasty balloon could not be advanced across the graft to complete the 
fenestration in a further 2 cases. The wire exited in the retroperitoneal space in 3 cases 
and wire entrapment within the needle was observed in a further 2 cases.  
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Fig 8.3.7 Introduction and deployment of the main aortic body device in vivo 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 16mm iliac extension Dacron endograft (Medtronic Inc, Minneapolis, Minnesota, USA) served as the main body 
device, and was introduced in the porcine aorta via the femoral access route. Under fluoroscopic control, the main 
aortic stent was positioned so that spaces between the metallic struts were located at the target vessel ostia and was 
then fully deployed across the visceral segment covering the target vessels. 
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Fig 8.3.8 Needle puncture and target vessel cannulation in vivo 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With the main aortic body device fully deployed, the fabric of the endograft is punctured with a 20G customized 
needle that is introduced, guided and supported via the robotic catheter. A 0.014-mm guide wire was threaded 
through the needle to cannulate the R renal artery. A 4 x 20 mm angioplasty balloon advanced over the wire can 
also be seen. The robotic catheter has been autoretracted to allow for balloon expansion.  
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Fig 8.3.9 Balloon dilatation and branch vessel stenting in vivo  
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Following needle puncture and target vessel cannulation, serial angioplasty balloon dilatation of the fenestrations 
and subsequent branch vessel stenting is shown. The robotic catheter is autoretracted and repositioned with fine 
movements to allow for balloon expansion until the waist of the balloon disappears, aiming at 90° angles to the 
vessel ostium and maintaining stability during stent deployment.  
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Rotational angiography was used in 5/8 animal cases in order to create an arterial 
roadmap, improve navigation and target localization (Fig 8.3.10). For the remaining 3 
cases, where rotational angiography technology was not available, the position of the 
target vessels was marked on the fluoroscopy screen in an anteroposterior (AP) 
projection. The 8F, 12MHz IVUS probe (In-Vision Gold; Volcano Corporation, 
Rancho Cordova, CA, USA) also used in 2 cases to enhance navigational accuracy, 
was inserted in the inferior vena cava and allowed visualization of the target vessel 
lumen, however, the aortic lumen could not be seen across the graft. A second IVUS 
probe positioned within the main aortic body could not clearly visualize outside the 
endograft, unless it was placed directly against the fabric of the device (Fig 8.3.11).  
 
Completion angiography confirmed good flow in 15/17 vessels. Vasospasm as well as 
small filling defects was seen at the distal portion of the branch vessel stents for 8 
vessels, suggesting a localized dissection; however, there was no evidence of flow 
limitation (Fig 8.3.12). Median procedure time was 75 min (IQR 60-90); median right 
renal artery coverage time was 17min (15-20) and median left renal artery coverage 
time was 23min (20-28). The median volume of contrast injected was 45ml (28-55). 
The estimated blood loss was less than 300mL. All swines tolerated the procedure 
well; blood pressure and heart rate remained stable throughout the procedure with no 
immediate complications.  
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Fig 8.3.10 Rotational angiography and arterial roadmapping  
 
The three-dimensional (3D) reconstructed arterial road map obtained after a 240° rotation of the C-arm and a 
single injection of iodinated contrast, is superimposed on the real-time two-dimensional fluoroscopic image. The 
robotic catheter and fenestration needle can be seen aiming towards the right renal artery. 
 
Fig 8.3.11 Intravascular ultrasound (IVUS) 
 
 
 
 
 
 
 
 
 
 
 
The IVUS probe positioned within the main aortic body was used to confirm the position of the SMA prior to 
puncture and cannulation in this case. It could only visualize the SMA lumen across the graft provided that the 
probe was placed against the fabric of the aortic device. Bilateral renal stents following antegrade in situ 
fenestration are also shown. 
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Fig 8.3.12 Completion angiography 
 
Completion angiography confirmed good flow in 15/17 vessels. Vasospasm as well as small filling defects were 
seen at the distal portion of the branch vessel stents in 8 cases, suggesting a localized dissection; however, there 
was no evidence of flow limitation 
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The animals were sacrificed later for autopsy. Macroscopic examination showed 
evidence of a retroperitoneal hematoma in one swine. There were no visible 
perforations of the aorta or any of the target vessels in all but 3 cases. There was 
evidence of small, localized dissections in 8 cases; for the remaining specimens 
however the intima was healthy and intact. 
 
The explanted endografts were subsequently analyzed with regards to the degree of 
fabric tear and seal adequacy. Specimen dissection confirmed fixation and sealing for 
all branch stents. Fabric evaluation revealed traces of puncture attempts and complete 
graft perforations, less than 0.3mm in size were observed in 3 cases.  
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8.4?Discussion 
 
In-situ fenestration of aortic stent grafts utilizing a remotely controlled robotic 
steerable catheter system is an attractive alternative to custom-made fenestrated and 
branched stent grafts to overcome some of the inherent limitations associated with 
these manufactured devices. Although clinical reports are scarce, there is ongoing 
interest to improve current materials and techniques using advanced technology to 
make this exciting new concept a viable option for a wholly endovascular approach of 
aortic pathologies. 
 
Current endografts are not specifically designed for the purpose of fashioning 
fenestrations and different fabrics react differently to perforation and subsequent 
dilatation. Consequently graft breaching and dilatation is one of the areas of greatest 
concern as longitudinal propagation of the fabric tear extending beyond the ostium of 
the target vessel may result in significant periostial endoleaks. The results of the 
preliminary in vitro experiment presented in this chapter suggest that compared with 
Dacron, PTFE is easier to perforate; the puncture can be readily dilated with a 
standard angioplasty balloon resulting in larger elliptical fenestrations. PTFE 
dilatation however, is more likely to result in propagating fabric tears at <90° 
dilatation angles. Microscopic analysis of 137 fenestrations revealed that fenestration 
quality is significantly higher when the needle is introduced at 90° angles and that 
angle is maintained during serial balloon dilatations. The highest fenestration quality 
in this bench qualitative and quantitative experiment was achieved in Medtronic 
Dacron stentgrafts showing circular fenestrations with clean margins, good fibre 
aggregation and low incidence of fabric tears; they were therefore chosen to serve as 
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the main body device for the in vivo part of this study. Cutting balloon use resulted in 
significantly more fabric-tears in all endograft types. Standard angioplasty balloons 
should therefore be preferred, as the number of ruptured fibers is limited in 
comparison, and the risk of arterial perforation is reduced.  
 
The antegrade approach to in-situ fenestration in particular, requires accurate 
positioning of the instruments used to ensure precise puncturing of the endograft. 
Modified needles are mostly used to perforate the endograft; these can be difficult to 
direct especially through tortuous vessels, and the tip usually requires an acute angle 
in order to perforate the graft accurately, to ensure that the fabric is punctured in the 
center of the ostium of the branch vessel. Rigid sheaths can be used to direct the 
needle through the graft; this however would require through and through access 
between the target vessel and the access vessel to facilitate its delivery and to 
minimize the risk of arterial trauma.  The Artisan robotic catheter acts as a flexible yet 
stable sheath, whereby a number of endovascular tools can be advanced through its 
lumen. The versatility of the robotic system, its precise positional orientation, 
minimum instrumentation of the vessel wall, and the ability to reproducibly and 
accurately return to sites of interest can facilitate in-situ fenestration of aortic stent 
grafts with minimal radiation exposure, as shown in the in vivo case series presented 
in this chapter. Stent-graft puncture and target-vessel cannulation with a guidewire 
was possible in 15/17 vessels attempted and subsequent branch-stent deployment was 
successful in 13/15 vessels. The robotic catheter tip was positioned against the fabric 
of the main body device, adjacent to the ostium of the target vessel to facilitate needle 
puncture and serial dilatation at 90° angles, in order to produce high quality 
fenestrations as shown in the in vitro phase of the study. Another important technical 
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aspect described in published reports of in situ fenestration techniques that may be 
overcome by use of the robotic system relates to the lack of control over where the 
fabric is punctured and dilated in relation to the endograft. The metallic struts of the 
graft endoskeleton should be avoided not only to ensure clean fenestration margins 
but also to minimize damage to the stent itself making it prone to early fatigue 
fractures.  
 
This study demonstrates the feasibility of robot-assisted antegrade in situ fenestration 
in vivo. The use of robotic technology results in accurate and stable puncture 
dilatation of aortic endografts at 90°angles for optimum fenestration quality, whilst 
facilitating branch vessel cannulation and subsequent stent placement. Several 
important issues however, need to be addressed prior to wider clinical applications: 
 
Endograft Design and Seal Durability 
 
The in situ fenestration approach to aortic stent grafting will require significant 
developments in aortic graft as well as branch stent construction and design not only 
to facilitate the fenestration process but also to ensure its long-term efficacy. The 
main aortic stent will require further development to allow free flow into the visceral 
vessels before fenestration as in the case of standard custom-made devices. The seal 
durability between the fenestration margins and the bridging stent, given the 
challenging hemodynamic environment of the arch and the physiological movements 
of the renal ostia below the diaphragm, is yet to be proven. The current uncertainty 
regarding the fenestration margins and seal may be addressed by designing 
“reinforced patches” within the endograft to specific target areas. The incorporation 
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of modified fabric or deformable metallic threads that will condense around the 
fenestration to form a stable sealing ring against which the bridging stent can engage, 
resulting in a durable seal. The graft endoskeleton will also need to be modified, to 
avoid the presence of struts at the target areas. Partial deployment of the endograft 
itself, by maintaining attachment to its delivery system may offer some additional 
support by avoiding kinking of the graft material by the puncturing needle during the 
fenestration process. 
 
Imaging 
 
Although stent graft technology has evolved, the mainstay of image guidance in most 
endovascular treatment suites remains fluoroscopic, with its attendant radiation 
exposure to patient and staff and need for nephrotoxic contrast agents. Accurate 
visualization of key aortic regions preoperatively, but most important, in “real-time,” 
is essential for the efficacy and safety of the in situ fenestration process. Current 
fluoroscopic methods lead to loss of 3-dimensional information, which can result in 
difficulties in positioning of the guiding wires, catheter, and stents especially in the 
presence of complex anatomy. Fluoroscopic landmarks can be used prior to endograft 
deployment; however, these methods provide 2-dimensional information regarding a 
3-dimensional object, the aorta. 
 
IVUS probes placed either within the endograft or the inferior vena cava have the 
potential to offer useful anatomical information with regards to the position of the 
target vessel ostia especially below the coeliac axis where vessel access is 
challenging. In this study, IVUS guidance did not offer a significant advantage over 
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conventional imaging techniques mainly due to the limitations of current IVUS 
technology. Computer tomographic rotational angiography is another alternative, 
which in this case series enhanced navigational accuracy by providing a static 2D 
anatomical roadmap.  
 
Both these imaging modalities, however, in their current form, do not offer 
reproducible, 3-dimensional, “real-time” navigation, which is essential for optimum 
accuracy and safety within the arterial tree. Ongoing research in our group is currently 
investigating advanced 3D navigational techniques involving impedance-based image 
registration systems and electromagnetic tracking of microposition sensors located at 
the tip of endovascular guidewires and catheters, which may enhance advanced 
endovascular applications such as in situ fenestration [Sidhu et al, 2010]. These 
technologies are currently widely applied in neurosurgery as well as cardiac mapping 
and ablation procedures [Harrisson SE et al, 2011; Steven D et al, 2010]. 
 
Fenestration Tools 
 
More sophisticated endovascular tools, such as RF devices  [Tse LW et al, 2010] and 
laser probes [Murphy EH et al, 2009] have recently been tested as adjuncts to improve 
fenestration quality and stability during the in situ process. RF ablation catheters are 
capable of creating full-size circular fenestrations with fused edges. Laser technology 
is promising especially with newer devices that burn a perfect circle through the wall 
of cerebral vessels using suction to hold on to the flap, preventing it from floating 
downstream and currently used for cerebral revascularization in neurosurgical 
procedures [Van Doormaal TP et al, 2008; Van Doormaal TP et al, 2010]. Current 
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devices, however, can be difficult to steer and control. Robotically steerable 
endovascular catheters provide an ideal platform for the introduction, manipulation 
and stability of endovascular tools and their compatibility with advanced navigation 
and imaging systems can further enhance the current and future methods of in situ 
fenestration.   
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8.5?Conclusions  
 
The management of complex aortic pathologies remains a major challenge, 
particularly in the emergency setting. Extensive preoperative planning, cost of 
custom-made endografts, and the technical difficulties encountered in complex 
anatomical configurations hinder the wider applications of minimally invasive 
endovascular therapy. Hybrid techniques represent transitional options bridging to a 
complete endovascular approach. In situ fenestration is an attractive alternative and is 
clearly feasible. Optimization of the current method using advanced catheter and 
navigation technologies can potentially accelerate its development in the clinical 
setting. Further research, long-term follow-up data, and significant improvements in 
endograft design, materials, and imaging are required to make it a reliable and 
reproducible endovascular option.  
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Chapter 9. 
First Clinical Application of Robotics in 
Endovascular Aneurysm Repair 
 
9.1?Background  
 
Prior to this research, clinical use of endovascular robotic technology was limited to 
transvenous cardiac mapping and ablation procedures [Kanagaratnam P et al, 2008; 
Saliba W et al, 2008, Di Biase L et al, 2009]. Following a comprehensive pre-clinical 
comparison and analysis of robotic versus manual catheter techniques in the arterial 
tree, this chapter reports the world’s first clinical application of endovascular robotics 
for endovascular aneurysm repair (EVAR), as a  “proof - of - concept”, in order to 
assess this novel and innovative approach in the clinical setting. 
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9.2?Clinical Case  
 
A 78-year-old man with chronic renal failure secondary to obstructive kidney disease 
(creatinine on admission 202 mmol/L) was admitted for elective repair of a 5.9-cm 
asymptomatic infrarenal abdominal aortic aneurysm (AAA), which had been under 
periodic ultrasound surveillance for 10 years. Following a standardized preoperative 
assessment protocol (dobutamine stress echocardiography, MAG-3 renal scanning, 
and lung function tests) and after discussion in our multidisciplinary forum, he was 
considered suitable for robot-assisted EVAR. Full, informed patient consent as well as 
approval by the Chairman of the Directors Board in our institution was obtained. 
 
 
9.3?Technique 
 
Following standardized training with the Hansen Sensei robotic system and after 
rehearsing the procedure in a laboratory environment, our group was able to 
undertake the first human case of robotically assisted endovascular infra-renal 
aneurysm repair. Under general anesthesia, the common femoral arteries were 
surgically exposed. After systemic heparinization (5000 units), a 28-316-mm-
diameter 3 170-mm-long bifurcated Endurant stent (Medtronic Vascular, Santa Rosa, 
CA, USA) was introduced via the right groin over standard 0.035-inch stiff Meier 
wires (Boston Scientific Corp; Natick, MA, USA) and deployed under fluoroscopic 
control with an imaging catheter that was placed through the left femoral access. The 
14F steerable robotic catheter was then introduced in the left femoral artery through 
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an 18F long access sheath. The virtual catheter image on the workstation screen was 
aligned with the robotic catheter in anteroposterior (AP) and 40° right and left 
anterior oblique configurations to improve navigational accuracy. The robotic catheter 
was driven into the aneurysm sac (Fig 9.3.1) utilizing the force-quantification system 
(Intellisense Technology). 
 
The steerable tip of the robotic catheter was remotely driven adjacent to the distal end 
of the contralateral limb of the main bifurcated stent body under fluoroscopic 
guidance. The position was confirmed in AP and lateral projections. The contralateral 
limb was successfully cannulated using fine and controlled movements in less than 
3min (Fig 9.3.2). The robotic catheter was then advanced to the level of the suprarenal 
aorta, and a 0.035-inch stiff Meier wire was passed through its lumen (Fig 9.3.3). The 
Artisan robotic catheter was autoretracted and removed through the 18F sheath. 
Completion angiography confirmed successful exclusion of the aneurysm with no 
immediate complications (Fig 9.3.4). No contrast was used during the robotic stage of 
the procedure; 38 mL of contrast used in total.  
 
Postoperatively, the patient made an uneventful recovery with no deterioration of the 
renal function. Computed tomography prior to discharge, at three months and yearly 
thereafter confirmed that the stent-graft remained in good position, with no evidence 
of an endoleak and adequate sac shrinkage. 
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Fig 9.3.1 Robotic cannulation and Intellisense technology 
 
 
 
The robotic catheter is driven into the aneurysm sac. A force-quantification system (Intellisense Technology) 
represented visually as a graph on the workstation screen ensures safe manipulation of the robotic catheter tip. The 
steerable tip is positioned adjacent to the distal end of the contralateral limb of the main bifurcated stent body 
under fluoroscopic guidance. The virtual catheter is also seen.  
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Fig 9.3.2 Robotic cannulation of the contralateral limb 
 
 
 
Successful cannulation of the contralateral EVAR limb. The inner guide of the Artisan catheter can be seen within 
the stentgraft, with the stiffer outer guide adding additional support for the passage of stiffwires. 
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Fig 9.3.3 Introduction of stiff guidewires through the robotic catheter 
 
 
 
The robotic catheter is advanced and a 0.035-inch stiff Meier wire is passed through its lumen. 
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Fig 9.3.4 Completion angiography 
 
 
 
Completion angiography showing successful aneurysm exclusion with no evidence of vessel damage. 
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9.4?Discussion 
 
With recent advances in endovascular technology, endovascular aneurysm repair has 
become an attractive alternative to open surgery for a range of aortic pathologies, with 
significantly reduced mortality and comparable long-term outcomes. Despite the 
exponential advances in endovascular equipment, devices and techniques, as 
discussed extensively in previous chapters, endovascular intervention has certain 
morphological and technological constraints.  
 
A remote robotic catheter system may help overcome some of the anatomical and 
technical difficulties associated with endovascular aneurysm repair, especially when 
tacking complex anatomical configurations. A steerable multidirectional catheter with 
a tight bend radius that allows fine and controlled movements in multiple planes may 
be useful when dealing with difficult contralateral gates in infrarenal stents or 
anatomically challenging target vessel cannulation in fenestrated and branched stent 
grafting. The system also minimizes operator radiation exposure, as the workstation is 
located outside the endovascular suite and away from the radiation source (Fig 9.4.1). 
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Fig 9.4.1 Robot-assisted EVAR: first patient application 
 
 
 
 
The operator manipulates the robotic catheter from the workstation outside the endovascular theatre suite, 
minimizing therefore radiation exposure.   
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This thesis has provided in-vitro and in-vivo evidence of the advantages of robotic 
catheter systems for endovascular intervention in terms of catheter maneuverability, 
stability, overcoming difficult anatomy, operator performance, safety, and skill 
acquisition. The world’s first robot-assisted endovascular aortic aneurysm repair 
presented in this chapter, received national and international press recognition (Smith 
R, 2008] and provided a proof-of-concept for robotic endovascular therapy in the 
arterial tree. Although the feasibility of robot-assisted aortic intervention in a clinical 
setting has been demonstrated, its role clearly lies in more complex endovascular 
procedures. To explore this further, we have initiated a trial, approved by our 
Institution and the Regional Ethics Committee, to assess and determine the safety and 
performance of endovascular robotic technology in the clinical setting with particular 
emphasis on fenestrated and branch endografting.  
 
 
 206 
9.5?Conclusions  
 
This initial clinical experience demonstrates that EVAR using robotically steerable 
catheters to cannulate the contralateral limb of an infrarenal stent-graft is technically 
feasible. Although these endografts are placed routinely without the need for such 
advanced technology, the authors believe that the steerable nature, flexibility, and 
stability of this robotic catheter system may be of benefit in more complex 
procedures, such as fenestrated stent-grafting, where fluoroscopic times are long and 
the anatomy more challenging. Further clinical evaluation of this promising 
technology is required in a randomized clinical trial setting. 
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Chapter 10. 
Summary and future research 
 
 
For over a decade, there has been a paradigm shift to an endovascular, minimally 
invasive approach whilst treating diseases of the aorta and its branches, with clear 
advantages in terms of morbidity and mortality in certain vascular beds, especially in 
patients with multiple co-morbidities that would otherwise be deemed unsuitable for 
traditional open surgical approaches. Endovascular intervention however, has certain 
morphological and anatomical constraints. Difficult anatomical targets may lead to 
prolonged endovascular instrumentation carrying significant risks to the patient such 
as distal embolization and vessel trauma, with increased fluoroscopic exposure and 
long overall procedure times. Furthermore, complex endovascular tasks require a 
refined set of operator skills and technical finesse that is usually acquired after years 
of experience and standardized training.  
 
Conventional endovascular catheter technology contributes to these technical 
limitations; with a limited repertoire of shapes and sizes, they are difficult to steer and 
lack active maneuverability of the tip. This manual control can hinder overall stability 
and control at key target areas necessitating frequent catheter changes and risking loss 
of wire position in challenging cases. Catheter movement in itself consists of a series 
of interactions, which occur between the catheter, the guidewire and the vessel wall. 
Although effective, it is this wall interaction, which is responsible for many of the 
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complications reported, as repeated instrumentation especially in the presence of 
vessel thrombus or calcification, increases the risk vessel dissection, perforation and 
distal embolization. Endovascular flexible robotic technology presents itself as an 
attractive option, with enhanced active maneuverability, control at the catheter tip and 
the promise of “off the wall”, centerline navigation remotely and away from the 
radiation source. 
 
This thesis examined the applicability of the Hansen Sensei system - originally 
designed for transvenous cardiac mapping and ablation procedures - in-vitro and in-
vivo to evaluate its role in the arterial tree. Robotic endovascular catheters offer 
advantages for target vessel cannulation and effectiveness in reducing procedure 
times with greater accuracy and minimal contact with the vessel wall, in complex 
endovascular intervention. Robotic cannulation seems to be significantly faster than 
standard cannulation using conventional endovascular catheters in the visceral 
segment as well as the aortic arch. The data suggests that the time taken to access 
target vessels may be reduced by 83% using robotic technology, with important 
implications for fluoroscopic exposure, radiation dose and overall procedure times. 
The number of movements at the catheter tip required to complete successful target 
vessel cannulation is also significantly reduced. This is likely a result of a greater 
range of motion with the robotic catheter and increased three-dimensional control. 
With conventional catheters the operator is required to make a series of movements, 
adjusting the amount of manual torque in order to reach a given target. The benefits 
using robotic technology are particularly evident with the more challenging 
anatomical configurations, whereas one may argue that advantages during simplex 
endovascular tasks may be less clinically relevant. 
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Mere target vessel catheterization however, does not necessarily reflect technical 
success in complex arterial intervention. Equally important is the ability to advance 
stiff guidewires and other endovascular tools whilst maintaining stability at target 
sites. The robotic system is effectively a steerable sheath supporting a more flexible 
inner guide. Consequently, the catheter resists the tendency to herniate back into the 
aorta even with shallow cannulation, as wires and other endovascular tools are being 
advanced through its lumen. In 216 stiff guidewire exchanges studied, robotic 
endovascular catheters maintained stability at target sites with zero deflection during 
stiff guidewire exchanges, independent of the distance the catheter was introduced 
into the target vessel and no loss of access. In contrast, conventional catheters 
required positioning at least 2cm into the target vessel in order to avoid catheter 
deflection and subsequent loss of access. Robotic catheters, demonstrated increased 
stability at the target vessel osmium; this may prove useful when tackling angulated 
aortic arches, aneurysm necks and tortuous branches. 
 
Tortuosity of the access vessels is another important factor to consider and constitutes 
a challenge to successful endovascular intervention. With increasing iliac tortuosity 
conventional catheter advancement and manipulation becomes more technically 
demanding. Angulation at the access end of the path trajectory directly impacts on 
manipulation at the distal end of the wire/catheter interface, with limited torquability 
and buckling of the selective catheter, resulting in multiple cannulation attempts with 
frequent catheter changes. Robotic catheter manipulation seems to be unaffected by 
iliac tortuosity severity with faster cannulation times, increased positional accuracy 
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and catheter control. Again these advantages were particularly evident in the more 
tortuous cases. 
 
Investigating the system further, an overall improvement in operator performance 
whilst attempting complex endovascular tasks was observed. With robotic techniques, 
operator groups with varying experience in conventional endovascular procedures 
obtained equal scores indicating that skill using conventional catheters does not 
translate to robotic competence. However, the scores obtained using the robotic 
catheter were similar to those of highly experienced operators using the conventional 
approach, despite a short training period on the robotic system. The acquisition of 
rudimentary endovascular skills in novice subjects was also assessed in a 5-week 
training programme examining conventional versus robotic catheter techniques. 
Robotic catheters, although more intricate, do not seem to take longer to master and 
offer clear advantages with regard to positional control, at a faster rate, with shorter 
learning curves and an earlier plateau. Robotic technology seems to be the intuitive 
and advanced skill acquisition occurs with minimal training. It may, therefore, have a 
significantly shorter path to proficiency allowing an increased number of trainees to 
attempt more complex endovascular tasks earlier and with a greater degree of safety. 
 
Endovascular robotic technology could be valuable for other advanced endovascular 
applications such as in-situ fenestration of aortic stent grafts, which would obviate the 
need for expensive, bespoke fenestrated stents that can take weeks to manufacture. 
The technique of robot-assisted in-situ fenestration may offer the option of total 
endovascular aneurysm repair to many patients who are either anatomically 
unsuitable for custom endovascular fenestrated stent grafting, those who require the 
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procedure on an urgent basis, or serve as a bail-out options during inadvertent branch 
coverage in standard endovascular repairs. To date, we have achieved antegrade, in-
situ fenestration in porcine models using the Hansen system in conjunction with 3-
dimensional rotational angiography and intravascular ultrasound.  Accurate 
positioning of the catheter tip within the main aortic body, and adjacent to the vessel 
ostia is crucial in this procedure. Its position must also be stable, so as to allow 
precise puncture of the stent-graft and subsequent target vessel cannulation, serial 
balloon dilatations and stenting. This and other advanced applications may be further 
enhanced by 3D navigation technology and robotics seems to be the ideal platform for 
the integration of advanced “real-time” imaging techniques, localization, simulation 
and pre-procedure rehearsal; the Hansen system is compatible with existing non-
fluoroscopic mapping systems such as NavX™ (St. Jude Medical, St. Paul, MN, 
USA). Integration of robotics with 3D navigation technology may further improve the 
accuracy of catheter positioning and manipulation, and is currently one of the main 
research focuses within our group [Sidhu R et al 2010, Lee SL et al 2011]; further 
work is currently underway in association with the department of Computing at 
Imperial College London. 
 
The Hansen Sensei system is limited by the large 14F sheath (11F inner guide) size of 
the Artisan robotic catheter, which may not be suitable for certain branch vessels 
especially in the presence of significant atherosclerosis and calcification. 
Furthermore, although the Artisan outer sheath adds stability to the system, it is 
constrained to one-way fixed angulation as it was originally designed for access to the 
right atrium via the IVC. Our team has worked closely with our industry associates 
(Hansen Medical, USA) over the last 2 years to develop a smaller, more flexible and 
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adaptable catheter which has now received CE marking for use in the peripheral 
arterial vasculature. The development of this next-generation robotic system 
(Magellan) was based on the original platform of the Sensei system but with 
significant modifications, which afford enhanced maneuverability through a 6F inner 
guide platform with a 130° multi-directional articulation, and a 9.5F sheath with an 
additional 90° multi-directional articulation. The Remote Catheter Manipulator 
(RCM) allows retraction, insertion, rotation and catheter angulation of both the leader 
catheter and sheath, as well as providing 6 degrees of freedom. Furthermore, a robotic 
wire manipulator allows remote insertion, rotation and retraction of hydrophilic wires. 
The workstation is again located outside the angiographic suite and away from the 
radiation source, allowing catheter manipulation via a “master-slave” mechanism; the 
virtual catheter image projected on the workstation monitors identifies degrees of 
catheter flexion and rotation inside the vessel lumen, enhancing positional accuracy 
and catheter control. This specifically designed robotic catheter has a unique potential 
to simplify complex endovascular procedures.  
 
The purchase, installation and maintenance costs of endovascular robotic technology, 
however, cannot be underestimated especially in the current financial climate of 
austerity. Our pre-clinical studies suggest that the time taken to access vessels may be 
reduced by 83% using robotic techniques, which for a complex four vessel fenestrated 
case in our institution in our earlier series would translate to an average 2hr 29 min 
reduction in operating time. Added benefits in terms of accuracy and radiation 
exposure make the use of flexible robotics an attractive option, however much will 
depend on the price of disposable components, clinical outcomes and the potential for 
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wider applicability. Clinical data and cost-effectiveness studies are essential for 
translation and wider adoption into healthcare.  
 
Following standardized training with the robotic system and after rehearsing the 
procedure in a laboratory environment, in August 2008, we were able to undertake the 
first human case of robotically assisted endovascular infra-renal aneurysm repair 
worldwide, receiving national and international press attention and providing proof of 
the concept for robotic endovascular therapy. Experience with the robot has allowed 
our group to perform early clinical cases and design a trial to study the use of this 
technology for branch vessel cannulation in fenestrated stent grafting as well as 
challenging aorto-iliac cases. Refining the technical aspects of robotic endovascular 
robotic intervention using in-vivo and in-vitro models and studying clinical outcomes 
of the next-generation robotic catheter (Magellan) as part of our ongoing clinical trial 
we aim to further evaluate the clinical use of this technology in conjunction with 
advanced imaging and navigation techniques.  
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10.1?Conclusions  
 
Despite recent advances in device technology for catheter-based peripheral arterial 
revascularization procedures, the inadequacy of conventional catheters for the 
variable and often unpredictable anatomy of patients with complex arterial disease 
implies that alternative catheter designs are essential. Complex endovascular 
procedures can be time consuming and require a high degree of technical performance 
and long training pathways as their success is determined largely by operator skill. 
This work suggests that in benchtop and in-vivo models, for most surgeons, complex 
endovascular procedures are easier to perform using the robotic steerable system. This 
translates into shorter fluoroscopic times, fewer catheter movements and vessel wall 
interactions, and less interference by complicating factors such as iliac tortuosity or 
shallow vessel catheterization. Integration of robotic technology into clinical practice 
may lead to improved catheter accuracy, stability and safety in comparison with 
conventional techniques whilst minimizing radiation exposure. Further development 
to optimize the use of endovascular robotics in the arterial tree and evaluation of this 
technology in the clinical setting is mandated prior to widespread applications. By 
refining and understanding the role of new technologies whilst developing new 
approaches to treating challenging cases, it is hoped that the applicability of 
minimally invasive endovascular intervention can be extended to a larger cohort of 
patients.  
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